Pre-eclampsia or poor fetal growth

O15_PREEC_OR_FETGRO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O36.5 Hospital discharge: ICD-9 — 6565A\|6565B Cause of death: ICD-10 — O36.5 Cause of death: ICD-9 — 6565A\|6565B 2 out of 7 registries used, show all original rules.	6277
4. Check minimum number of events None	6277
5. Include endpoints O15_PRE_OR_ECLAMPSIA	16372
6. Filter based on genotype QC (FinnGen only)	14840

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	O15_PREEC_OR_FETGRO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	O15_PRE_OR_ECLAMPSIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O365
HD_ICD_9	6565A\|6565B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O365
COD_ICD_9	6565A\|6565B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-eclampsia or poor fetal growth based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	106315	106315	-
Only index persons	104055	104055	-
Unadjusted period prevalence (%)
Whole population	3.05	3.05	-
Only index persons	3.83	3.83	-
Median age at first event (years)
Whole population	-	28.82	-
Only index persons	-	28.80	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14840	14840	-
Unadjusted period prevalence (%)	5.27	5.27	-
Median age at first event (years)	29.25	29.25	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15390: Matched controls
153183

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8811

FHL

Cesarean section

3.0

317.0

1519

5353

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.3

307.7

5602

30636

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

7.7

307.7

3151

4980

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

307.7

347

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

307.7

2170

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.0

307.7

4179

17015

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

307.7

1353

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

10888.3

307.7

2742

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.0

307.7

2335

8645

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

3.0

307.7

3693

14603

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

307.7

381

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

307.7

465

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

2073.4

307.7

5228

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

809.2

307.7

2166

C07AG01

ATC

labetalol; systemic

11.7

307.7

764

678

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

2.7

307.7

2164

8753

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

+∞

307.7

498

O14.1

ICD-10 Finland

Severe pre-eclampsia

12453.6

307.7

1168

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

6.9

307.7

946

1443

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.8

307.7

3510

14397

205

Kela drug reimbursment

Chronic hypertension

2.5

300.6

2243

9896

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

+∞

298.4

286

66120

ICD-8 Finland

Occipital presentation

+∞

285.8

274

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.9

285.1

4784

28899

W84

ICPC

Pregnancy high risk

2.8

280.7

1528

5760

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.8

280.0

6880

46861

Z39.2

ICD-10 Finland

Routine postpartum follow-up

1.9

273.6

4541

27259

O41.0

ICD-10 Finland

Oligohydramnios

3.9

265.0

802

2105

O60

ICD-10 Finland

Preterm labour and delivery

3.4

252.5

980

3035

XMA22

NOMESCO Finland

General examination of pregnant woman

2.4

247.6

1977

8942

SPAT1379

SPAT

Health check-up of pregnant person

2.0

247.6

3704

21353

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

246.0

236

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

6.6

245.9

400

615

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

3.6

240.1

833

2399

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

3.2

236.0

983

3177

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

231.7

6435

44666

C09AA02

ATC

enalapril; systemic

2.3

225.3

1866

8555

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

543.3

217.3

216

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.4

212.2

1597

7010

O12.1

ICD-10 Finland

Gestational proteinuria

7.0

206.1

316

456

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.0

205.1

2745

15113

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

5.3

205.1

417

795

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

202.2

194

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.0

200.9

2655

14543

W78

ICPC

Pregnancy

1.7

199.0

4787

31578

SPAT1197

SPAT

Extensive health check-up of expecting family

1.8

193.7

3993

25166

ZXD05

NOMESCO Finland

Urgent procedure

1.7

189.3

5043

34107

C08CA05

ATC

nifedipine; systemic

3.1

188.9

855

2894

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

4.6

185.1

446

982

63799

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified

+∞

183.4

176

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.6

178.3

1112

4458

MAA00

NOMESCO Finland

Amniocentesis

3.1

172.1

748

2471

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.6

170.3

579

1641

SPAT1380

SPAT

Postpartum check-up

1.8

165.3

2994

18040

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.8

163.3

3091

18862

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.0

156.2

1954

10425

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.2

153.7

1401

6633

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

2.1

147.8

1521

7548

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

8.8

147.3

185

211

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.7

145.9

831

3177

C08CA01

ATC

amlodipine; oral

1.7

141.8

3568

23433

O30.0

ICD-10 Finland

Twin pregnancy

3.3

140.3

542

1666

A10AC01

ATC

insulin (human); parenteral

2.4

140.2

1058

4620

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

2.0

139.5

1786

9582

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

133.5

2520

15267

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

131.3

2486

15065

WX320

NOMESCO Finland

Spinalanesthesy

1.6

125.5

3427

22871

O16

ICD-10 Finland

Unspecified maternal hypertension

6.1

120.9

211

348

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.6

114.0

2931

19206

A10BA02

ATC

metformin; oral

1.6

111.2

2840

18567

O32.1

ICD-10 Finland

Maternal care for breech presentation

2.0

110.6

1240

6324

A10AE04

ATC

insulin glargine; parenteral

2.2

109.5

1037

4962

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.5

105.5

4055

29086

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.6

105.2

618

2394

SPAT1196

SPAT

Monitoring of normal pregnancy

1.8

104.2

1942

11652

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.6

103.8

2553

16499

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

2.6

103.6

619

2418

A10AB05

ATC

insulin aspart; parenteral

2.2

101.7

909

4248

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.5

101.7

669

2737

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.7

101.3

566

2138

C07AB02

ATC

metoprolol; systemic

1.8

101.2

1851

11040

SPAT1262

SPAT

Handing over of treatment supplies

1.7

96.6

1800

10782

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.1

95.9

419

1385

T90

ICPC

Diabetes non-insulin dependent

1.6

93.0

2222

14219

W92

ICPC

Compl labour/ delivery livebirth

2.3

92.8

713

3127

40199

ICD-8 Finland

Essential benign hypertension

6.2

90.4

154

248

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

89.4

1996

12542

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.5

86.8

2865

19755

C09BA02

ATC

enalapril and diuretics; systemic

2.5

86.0

586

2435

SPAT1263

SPAT

Sampling

1.4

82.8

6259

50446

O99.80

ICD-10 Finland

The fear of childbirth

1.8

82.0

1441

8466

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.1

81.6

772

3684

63709

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD

+∞

80.1

OAA11, ,

SPAT

1.7

79.7

1703

10557

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

78.9

580

2493

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

77.0

6086

49224

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.3

76.0

597

2641

A10AB01

ATC

insulin (human); parenteral

2.4

73.1

503

2099

W81

ICPC

Toxaemia of pregnancy

15.7

73.0

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

73.0

1974

12956

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.5

71.2

2322

15893

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

4.2

70.4

189

453

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

69.7

1655

10520

C02EA02, ,

ATC

3.7

69.6

220

593

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

69.6

734

3647

66180

ICD-8 Finland

Occipital presentation

2.9

69.5

334

1165

B01AB05

ATC

enoxaparin; parenteral

1.4

69.5

3815

28895

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

69.3

329

1140

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

68.7

698

3421

A10AE05

ATC

insulin detemir; parenteral

2.2

68.1

613

2867

C02CB01, ,

ATC

13.4

66.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

66.7

1938

12913

C07AB07

ATC

bisoprolol; oral

1.4

66.2

4567

35893

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

7.6

65.2

121

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

9.7

64.7

A10AB04

ATC

insulin lispro; parenteral

2.3

64.4

480

2075

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

63.7

468

2010

OAA12, ,

SPAT

1.7

63.5

1238

7467

FM1NE

NOMESCO Finland

Ultrasound examination of fetal heart

3.6

63.0

207

573

MAX99

NOMESCO Finland

Assistance to normal delivery

1.5

62.7

2511

17887

A10BJ06

ATC

semaglutide; parenteral

2.0

61.4

675

3402

C09CA01

ATC

losartan; oral

1.5

61.1

2342

16531

OAA10, ,

SPAT

1.7

60.9

1206

7301

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

4.6

60.4

142

307

O61.0

ICD-10 Finland

Failed medical induction of labour

2.8

60.3

318

1166

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.3

58.9

6208

51765

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

2.9

58.8

289

1021

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.9

58.7

274

941

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

57.9

598

2947

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

57.8

2657

19397

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

57.5

2136

14963

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

3.7

56.5

183

502

C08CA02

ATC

felodipine; oral

2.0

55.8

657

3392

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.9

55.3

751

4066

A10AA02, ,

ATC

2.4

55.0

387

1631

C03CA01

ATC

furosemide; systemic

1.5

54.8

1896

13079

C08CA13

ATC

lercanidipine; oral

1.6

54.8

1226

7655

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.1

54.7

152

374

T89

ICPC

Diabetes insulin dependent

2.1

54.6

550

2685

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.6

54.2

1590

10587

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.5

54.0

2292

16462

MAC98

NOMESCO Finland

Other induction of labor

4.5

53.9

131

291

A10AA01, ,

ATC

2.4

53.5

374

1572

W29

ICPC

Pregnancy symptom/complaint other

1.8

53.3

770

4250

A10BK03

ATC

empagliflozin; oral

1.8

52.7

884

5103

6563B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]

2.5

52.6

350

1438

O84.2

ICD-10 Finland

Multiple delivery, all by caesarean section

4.0

52.6

151

381

C09DA01

ATC

losartan and diuretics; oral

1.7

52.5

943

5553

SPAT1301

SPAT

No procedures

1.3

51.5

3959

31379

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

2.1

50.8

506

2459

O36.3

ICD-10 Finland

Maternal care for signs of fetal hypoxia

3.5

50.7

176

506

W85

ICPC

Gestational diabetes

1.6

50.1

1132

7081

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

2.9

50.0

233

800

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

49.9

1355

8856

C02AC05

ATC

moxonidine; oral

2.4

49.3

332

1372

H04AA01

ATC

glucagon; nasal, parenteral

2.3

48.4

374

1642

OAB50, ,

SPAT

1.7

48.4

868

5105

O02.1

ICD-10 Finland

Missed abortion

1.6

48.4

1289

8386

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

1.6

48.3

1066

6625

W90

ICPC

Uncompl labour/delivery livebirth

1.6

48.0

1315

8611

MA3AE

NOMESCO Finland

Combined first trimester screening

1.5

47.1

1506

10202

Z35.4

ICD-10 Finland

Supervision of pregnancy with grand multiparity

2.9

47.0

226

789

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

6.9

47.0

104

O12.0

ICD-10 Finland

Gestational oedema

3.5

46.9

159

450

Z39.1

ICD-10 Finland

Care and examination of lactating mother

1.9

46.9

593

3136

SPAT1310

SPAT

Counselling related to known health issue

1.3

46.8

4279

34677

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

46.1

144

386

Z30.2

ICD-10 Finland

Sterilization

1.5

46.0

1884

13407

C03AA03

ATC

hydrochlorothiazide; oral

1.8

45.4

676

3765

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.7

45.1

836

4962

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

1.9

44.6

579

3088

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

44.6

256

981

ZXD00

NOMESCO Finland

Emergency procedure

2.0

44.3

469

2332

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

1.8

44.3

692

3911

O20.0

ICD-10 Finland

Threatened abortion

1.9

44.0

593

3201

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

43.7

1953

14113

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

2.5

42.9

282

1153

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

2.1

42.7

414

1993

WX290

NOMESCO Finland

Other blockage of nerve

1.3

42.1

8017

70929

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

41.6

6308

54301

WX892

NOMESCO Finland

Monitored bed care

1.8

41.3

680

3903

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.1

40.9

401

1938

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

3.1

40.7

174

569

O35.9

ICD-10 Finland

Maternal care for (suspected) fetal abnormality and damage, unspecified

2.5

40.7

264

1073

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.3

40.7

305

1323

H3603, E103,

ICD-10 Finland

3.2

40.5

162

510

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

11.0

40.4

A10BB12

ATC

glimepiride; oral

2.3

40.3

303

1316

E66.8

ICD-10 Finland

Other obesity

1.6

40.1

1062

6890

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.0

40.1

433

2168

ZXE00

NOMESCO Finland

One hour or less

1.3

39.9

5361

45426

O43.8

ICD-10 Finland

Other placental disorders

7.9

39.8

J01DB01

ATC

cefalexin; oral

1.3

39.7

12436

116457

A10BK01

ATC

dapagliflozin; oral

1.8

39.4

658

3792

K02.1

ICD-10 Finland

Caries of dentine

1.3

39.3

9415

85196

OAA41, ,

SPAT

1.8

39.0

634

3625

K85

ICPC

Elevated blood pressure

1.5

38.9

1556

11000

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

2.1

38.9

383

1854

C09DA06

ATC

candesartan and diuretics; oral

1.7

38.9

708

4179

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

1.9

38.9

495

2623

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.9

38.4

111

282

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

38.2

1985

14705

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

38.0

1233

8361

C09AA05

ATC

ramipril; oral

1.4

38.0

1556

11050

A12BA01

ATC

potassium chloride; oral

2.6

37.6

215

823

A10AE06

ATC

insulin degludec; parenteral

2.0

36.7

419

2140

E66.9

ICD-10 Finland

Obesity, unspecified

1.7

36.6

633

3682

J01DA01

ATC

[U] cefalexin

1.2

36.5

8824

79573

C09CA06

ATC

candesartan; oral

1.3

36.5

3040

24175

6563A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, RASKAUDEN AIKANA]

6.1

36.2

104

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.0

36.2

163

550

O15.0

ICD-10 Finland

Eclampsia in pregnancy

356.6

35.9

C10AA01

ATC

simvastatin; oral

1.3

35.9

2488

19269

C07AG02

ATC

carvedilol; oral

2.1

35.8

363

1777

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

2.2

35.8

310

1429

H3601, E103,

ICD-10 Finland

3.1

35.6

146

467

A10BH01

ATC

sitagliptin; oral

1.7

35.5

684

4098

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

35.0

654

3887

H3600, E103,

ICD-10 Finland

2.8

34.8

181

660

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

34.8

102

262

O36.4

ICD-10 Finland

Maternal care for intrauterine death

3.1

34.3

145

472

C10AA05

ATC

atorvastatin; oral

1.3

33.7

3287

26656

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

1.5

33.5

980

6495

SGA01

NOMESCO Finland

Emergency treatment

1.3

33.4

2578

20256

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

33.4

799

5059

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

3.7

33.3

107

293

O28.3

ICD-10 Finland

Abnormal ultrasonic finding on antenatal screening of mother

2.6

33.3

191

733

N02BE01

ATC

paracetamol; systemic, rectal

1.3

33.2

13249

125899

C10AX09

ATC

ezetimibe; oral

1.5

33.1

1303

9174

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.1

32.9

329

1603

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

2.5

32.7

203

809

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

32.7

140

459

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.5

32.6

201

799

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

2.5

32.4

198

784

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

32.2

638

3851

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.4

31.7

228

973

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

31.5

11557

108078

O46.9

ICD-10 Finland

Antepartum haemorrhage, unspecified

1.9

31.4

399

2113

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.4

31.4

218

915

Z3232

NOMESCO Finland

Midwife

1.3

31.4

2026

15495

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.4

31.4

222

940

A02BC01

ATC

omeprazole; systemic

1.3

31.2

3299

26985

K86

ICPC

Hypertension uncomplicated

1.5

31.0

1051

7182

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

2.6

30.8

184

720

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

30.8

542

3170

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

30.6

1593

11777

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

2.2

30.5

262

1205

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

2.0

30.2

350

1799

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

30.1

161

597

160

Kela drug reimbursment

exenatide

2.5

30.0

183

724

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

29.8

5854

51224

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

1.5

29.6

952

6434

SFA10

NOMESCO Finland

One-surface restoration

1.2

29.6

8482

77013

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

1.7

29.5

504

2923

SPAT1153

SPAT

Removal of sutures

1.3

29.4

3269

26869

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

29.3

4642

39707

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

3.3

29.0

107

321

SFA20

NOMESCO Finland

Two-surface restoration

1.2

28.9

9150

83790

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

1.7

28.8

585

3554

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

28.7

173

681

O84.0

ICD-10 Finland

Multiple delivery, all spontaneous

2.7

28.5

156

585

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

27.9

130

448

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

27.9

4732

40718

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

27.8

260

1237

J01CA08

ATC

pivmecillinam; oral

1.2

27.7

7822

70701

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.4

27.7

198

843

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

27.2

3206

26496

6427A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]

+∞

27.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

27.0

1087

7676

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

26.7

3581

30024

O47.9

ICD-10 Finland

False labour, unspecified

1.8

26.7

410

2307

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

26.6

276

1364

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.1

26.6

266

1298

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

1.9

26.6

316

1639

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

26.4

7023

63008

A10AD01

ATC

insulin (human); parenteral

2.4

26.1

174

718

SPAT1312

SPAT

General health counselling

1.2

26.1

4404

37809

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

26.1

1195

8635

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.0

26.1

112

369

WX234

NOMESCO Finland

Paracervical blockade

1.5

26.0

725

4753

W27

ICPC

Fear of complications of pregnancy

2.0

26.0

285

1438

Z37.2

ICD-10 Finland

Twins, both liveborn

3.4

25.9

265

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

2.3

25.8

201

889

A10BJ02

ATC

liraglutide; parenteral

1.8

25.7

368

2027

K04.0

ICD-10 Finland

Pulpitis

1.4

25.6

1459

10926

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.3

25.6

3079

25479

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

25.6

152

595

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

25.3

4574

39515

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

25.2

4659

40336

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

4.6

25.2

128

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

1.6

24.9

642

4135

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.6

24.8

583

3676

SFA30

NOMESCO Finland

Three-surface restoration

1.2

24.7

5628

49671

O46.0

ICD-10 Finland

Antepartum haemorrhage with coagulation defect

8.4

24.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

24.7

10943

102585

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.1

24.7

240

1159

O45.9

ICD-10 Finland

Premature separation of placenta, unspecified

3.3

24.6

279

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

24.3

8196

74881

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.4

24.3

164

682

65700

ICD-8 Finland

Occipital presentation

2.6

24.1

141

548

C07FB02

ATC

metoprolol and felodipine; systemic

2.5

24.0

152

613

O03.4

ICD-10 Finland

Spontaneous abortion, Incomplete, without complication

1.7

24.0

486

2952

O30.01

ICD-10 Finland

Twin pregnancy with a shared chorionic sac and a separate amniotic sac

4.2

23.7

151

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

23.6

895

6248

C03BA11

ATC

indapamide; oral

2.2

23.5

192

867

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

23.4

721

4828

C01DA14

ATC

isosorbide mononitrate; oral

1.6

23.4

489

2995

O61.1

ICD-10 Finland

Failed instrumental induction of labour

3.2

23.4

283

A08AB01

ATC

orlistat; oral

3.4

23.4

239

C07AB08

ATC

celiprolol; oral

2.6

23.2

131

500

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

23.1

190

860

R51.80

ICD-10 Finland

Headache

1.3

23.1

2599

21318

SPAT1097

SPAT

Recording of ECG

1.4

23.0

1178

8671

8221

FHL

Sterilization of the laparotomy pathway

1.8

22.9

376

2157

A10BX07

ATC

[U] liraglutide

2.8

22.9

114

408

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.0

22.9

100

333

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

22.8

4605

40108

W05

ICPC

Pregnancy vomiting/nausea

2.0

22.8

257

1310

C09CA03

ATC

valsartan; oral

1.5

22.8

659

4356

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

4.0

22.6

161

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

22.5

849

5919

A10BJ05

ATC

dulaglutide; parenteral

2.1

22.5

203

954

M04AA01

ATC

allopurinol; systemic

1.6

22.4

527

3322

SPAT1260

SPAT

Consultation of another employee

1.3

22.3

2054

16442

P01AB01

ATC

metronidazole; oral, rectal

1.2

22.1

6164

55215

O61.8

ICD-10 Finland

Other failed induction of labour

2.9

22.1

103

356

WYA40

NOMESCO Finland

Assessment of oral health and treatment needs for family expecting first child

1.7

22.0

437

2642

Z36.8

ICD-10 Finland

Other antenatal screening

1.6

21.9

453

2769

O20.8

ICD-10 Finland

Other haemorrhage in early pregnancy

2.3

21.9

160

690

O35.6

ICD-10 Finland

Maternal care for (suspected) damage to fetus by radiation

62.3

21.8

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

21.8

1225

9150

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

21.7

1018

7383

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.1

21.4

288

6542B

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, SYNNYTYKSEN AIKANA]

2.3

21.4

155

665

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

21.4

143

592

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

21.4

2808

23406

6510A

ICD-9 Finland

Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]

3.2

21.3

259

EBA00

NOMESCO Finland

Extraction of tooth

1.2

21.1

4866

42822

C10AA07

ATC

rosuvastatin; oral

1.2

21.1

3251

27548

C07AB03

ATC

atenolol; systemic

1.8

21.1

325

1833

6542A

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, RASKAUDEN AIKANA]

3.1

21.0

271

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

20.8

5689

50790

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.5

20.8

130

522

C08CA10

ATC

nilvadipine; oral

2.7

20.8

114

430

EB1VA, ,

NOMESCO Finland

1.2

20.7

2560

21189

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.5

20.7

195

SPAT1240

SPAT

Therapeutic discussion

1.3

20.6

1805

14344

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.5

20.6

627

4191

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

20.5

596

3942

OAA70, ,

SPAT

1.6

20.4

458

2856

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.2

20.3

160

712

SPAT1254

SPAT

Administration of medicine

1.3

20.2

1371

10525

B01AC04

ATC

clopidogrel; oral

1.5

20.2

703

4828

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

20.1

1210

9127

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

20.1

233

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

19.9

1535

11992

C09DA03

ATC

valsartan and diuretics; oral

1.7

19.9

331

1907

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

1.9

19.9

233

1205

O14

ICD-10 Finland

Pre-eclampsia

23.3

19.8

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

1.9

19.8

252

1339

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

19.8

2308

18970

R09

ICPC

Sinus symptom/complaint

1.3

19.8

1493

11631

6412B

ICD-9 Finland

Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]

4.4

19.7

112

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

19.6

3909

33917

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

19.5

880

6337

N97.0

ICD-10 Finland

Female infertility associated with anovulation

1.6

19.5

457

2882

SPAT1283

SPAT

Restricted health certificate

1.2

19.5

3462

29714

G47.3

ICD-10 Finland

Sleep apnoea

1.2

19.3

2210

18126

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.4

19.2

808

5747

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.3

19.0

141

612

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

19.0

1256

9608

W03

ICPC

Antepartum bleeding

2.0

18.8

199

993

C03DA01

ATC

spironolactone; oral

1.4

18.8

871

6300

6426A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]

+∞

18.7

B01AB10

ATC

tinzaparin; parenteral

1.3

18.7

1225

9359

O03.1

ICD-10 Finland

Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage

1.7

18.5

330

1940

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

18.5

3123

26657

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

18.4

1467

11507

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

18.3

1464

11494

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.7

18.1

312

1817

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

1.6

18.1

413

2587

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.7

18.1

351

XLD10

NOMESCO Finland

Gynaecological examination

2.1

18.0

168

801

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

18.0

412

2585

B05DB

ATC

Hypertonic solutions

3.6

17.9

156

C07BB07

ATC

bisoprolol and thiazides; systemic

1.8

17.9

274

1543

T82

ICPC

Obesity

1.4

17.8

711

5011

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.3

17.8

131

568

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

17.7

373

2291

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

17.7

1446

11377

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.0

17.7

181

893

Z94.0

ICD-10 Finland

Kidney transplant status

2.6

17.7

101

389

N02AX02

ATC

tramadol; systemic, rectal

1.2

17.7

4811

42774

SPAT1192

SPAT

Gynaecological examination

1.2

17.7

2200

18194

A46

ICD-10 Finland

Erysipelas

1.3

17.6

1046

7874

M54.5

ICD-10 Finland

Low back pain

1.2

17.5

5362

48119

MBA04

NOMESCO Finland

Curettage of uterus after delivery

2.2

17.4

147

674

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

17.4

1517

12037

MBA96

NOMESCO Finland

Other removal of retained products of conception after delivery or abortion

1.6

17.4

391

2442

R80

ICD-10 Finland

Isolated proteinuria

2.8

17.3

303

C08DB01

ATC

diltiazem; oral

1.9

17.3

226

1213

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

17.2

10824

102488

Y6099

ICD-8 Finland

Prenatal care and observation

1.5

17.2

488

3215

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.3

17.2

1828

14857

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

17.1

5681

51271

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

17.0

1921

15713

66170, ,

ICD-8 Finland

3.4

16.9

172

B05DA

ATC

Isotonic solutions

3.4

16.9

177

O40

ICD-10 Finland

Polyhydramnios

1.8

16.9

246

1366

MBA30

NOMESCO Finland

Manual removal of placenta from delivered uterus

1.7

16.8

340

2068

6423B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]

4.9

16.7

O15.1

ICD-10 Finland

Eclampsia in labour

+∞

16.6

MA3AE, ,

SPAT

2.1

16.6

157

753

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

16.6

216

1158

WX704

NOMESCO Finland

Intubation

1.3

16.5

961

7210

6580A

ICD-9 Finland

Other problems associated with amniotic cavity and membranes, Oligohydramnios[OLIGOHYDRAMNION, RASKAUDEN AIKANA]

6.4

16.5

MBA40

NOMESCO Finland

Pharmacological evacuation of uterus after abortion

1.6

16.5

340

2080

J01FF01

ATC

clindamycin; systemic

1.2

16.4

3225

27868

A10BH05

ATC

linagliptin; oral

1.8

16.4

251

1415

O24.3

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified

5.9

16.4

C09AA03

ATC

lisinopril; oral

1.8

16.4

255

1445

162

Kela drug reimbursment

liraglutide

2.6

16.3

370

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

16.3

292

1721

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

16.3

249

1404

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

16.1

442

2892

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

16.0

243

1366

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

16.0

2564

21741

J01CA04

ATC

amoxicillin; systemic

1.2

15.9

12583

120889

MBA20

NOMESCO Finland

Expression of placenta

2.1

15.8

155

754

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

15.8

193

1014

J01AA02

ATC

doxycycline; systemic

1.2

15.8

10791

102380

O64.1

ICD-10 Finland

Obstructed labour due to breech presentation

1.7

15.8

302

1812

Z49.2

ICD-10 Finland

Other dialysis

3.3

15.8

180

A10BX04

ATC

[U] exenatide

2.6

15.7

337

G02CB01

ATC

bromocriptine; systemic

1.7

15.6

313

1901

SGC10

NOMESCO Finland

Pulp capping

1.3

15.6

1294

10198

B01AB04

ATC

dalteparin; parenteral

1.5

15.6

517

3518

AA1AD

NOMESCO Finland

CT of head and brain

1.2

15.6

2367

19957

C09DA07

ATC

telmisartan and diuretics; oral

1.7

15.5

294

1759

O72.0

ICD-10 Finland

Third-stage haemorrhage

1.5

15.5

459

3051

O84.8

ICD-10 Finland

Other multiple delivery

2.9

15.5

255

137

Kela drug reimbursment

Uraemia requiring dialysis

3.0

15.4

229

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.4

15.4

777

5702

Z19

ICPC

Loss/death of child problem

3.3

15.4

168

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

15.3

230

1291

C07AA03

ATC

pindolol; systemic

3.2

15.2

189

O45.8

ICD-10 Finland

Other premature separation of placenta

3.6

15.2

136

O43.9

ICD-10 Finland

Placental disorder, unspecified

6.9

15.1

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

1.4

15.1

732

5338

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

15.0

985

7520

A10AA03, ,

ATC

2.5

14.9

351

A10BG03

ATC

pioglitazone; oral

2.0

14.9

154

764

A10AB06

ATC

insulin glulisine; parenteral

2.5

14.9

387

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.2

14.9

124

567

O72.1

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012516) Albumin [Mass/volume] in Urine

5062

30182

2.00

320.92

4.3

3.4

126.86

33.63

mg/l

47.52

3485

17514

(3020682) Albumin/Creatinine [Ratio] in Urine

5133

30529

2.01

307.65

5.2

3.9

22.18

6.34

mg/mmol

48.74

3504

17623

(3009508) Creatinine [Moles/volume] in Urine

5613

36565

1.83

258.54

4.3

3.2

7.19

7.29

mmol/l

0.95

4945

31936

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2102

10556

2.14

201.61

4.1

4.0

238.12

230.95

u/l

0.82

2014

10056

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1919

9816

2.08

173.60

1.8

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1510

7289

2.18

158.05

1.6

1.5

59.48

60.32

ug/l

0.29

1510

7289

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

944

3732

2.62

155.17

3.0

1.7

1.17

1.45

g/l

18.13

848

3246

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3261

20700

1.72

148.11

1.7

1.6

925.10

1027.06

mu/l

7.36

2775

17295

(3026493) Urate [Moles/volume] in Serum or Plasma

4292

30743

1.54

114.12

2.9

2.1

315.37

297.78

umol/l

32.19

3917

27824

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5232

40045

1.46

96.69

2.0

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4387

32694

1.47

92.11

1.9

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

887

4345

2.10

87.70

2.5

2.4

3.94

3.56

g/l

12.63

834

4135

(3013826) Glucose [Moles/volume] in Serum or Plasma

8530

72603

1.38

79.73

4.9

4.2

6.52

6.27

mmol/l

17.97

7723

66577

(3032080) INR in Blood by Coagulation assay

5811

46514

1.39

78.85

8.5

7.6

1.09

inr

0.52

4905

37993

(3029937) Albumin [Presence] in Urine by Test strip

5150

40711

1.39

74.01

4.3

3.7

0.00

estimate

0.04

2090

15372

(3050129) First trimester maternal screen panel - Serum or Plasma

2062

13745

1.57

71.23

1.5

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10865

97219

1.38

68.41

5.0

4.3

1.17

6.89

—

112

(3035350) Ketones [Presence] in Urine by Test strip

8907

77283

1.35

68.26

4.2

3.6

1.22

3.78

estimate

1.85

2193

16072

(3034274) Bile acid [Moles/volume] in Serum --fasting

875

4657

1.92

68.12

2.4

2.2

5.36

5.24

umol/l

0.12

647

3375

(3009261) Glucose [Presence] in Urine by Test strip

8954

77853

1.35

67.08

4.3

3.6

0.01

0.21

estimate

1.11

2099

15690

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8007

68499

1.34

66.75

2.9

2.6

—

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

8797

76488

1.34

64.74

4.2

3.5

0.00

estimate

0.06

2168

15839

(3020876) Protein [Mass/time] in 24 hour Urine

283

941

3.03

64.14

3.1

2.3

1.42

1.06

g/24h

1.79

173

519

(3031040) Bacteria [#/volume] in Urine by Automated count

10508

93991

1.36

62.97

5.0

4.2

1576.42

2030.40

e6/l

0.22

112

1051

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6964

58802

1.33

61.38

4.0

3.4

0.69

0.23

estimate

0.60

1849

13152

(3023103) Potassium [Moles/volume] in Serum or Plasma

14053

132869

1.61

57.97

14.8

12.2

3.91

3.90

mmol/l

9.75

13797

129927

(3019550) Sodium [Moles/volume] in Serum or Plasma

14034

132659

1.60

57.80

14.6

12.1

139.45

139.65

mmol/l

21.43

13793

130026

(3041096) Erythrocytes [Presence] in Urine by Automated

5358

44396

1.31

50.88

3.4

2.9

0.22

0.11

estimate

0.35

1864

13165

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4122

33069

1.33

48.88

2.1

1.7

1.26

0.90

mg/l

7.58

3221

25099

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2132

15558

1.42

45.35

2.2

2.0

28.60

28.98

2.39

2056

15095

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2080

15178

1.42

44.15

2.7

2.2

7990.11

6003.09

u/l

2.05

1002

6244

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4869

40434

1.29

43.64

3.1

2.7

26.79

46.22

ng/l

0.59

2461

18985

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

592

3204

1.87

43.57

3.8

2.9

1.46

1.30

mg/l

5.70

559

2980

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

364

1661

2.21

42.99

2.8

2.4

133.45

53.52

ug/min

1.96

240

1022

(40761536) Microorganisms panel - Urine sediment

1710

12096

1.46

42.89

4.0

3.4

—

(3037121) Protein [Mass/volume] in Urine

631

3533

1.81

41.63

3.3

2.9

512.29

347.37

mg/l

2.08

325

1386

(46235355) HIV 1 and 2 tests - Meaningful Use set

5492

46546

1.27

41.15

2.2

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6185

53459

1.25

38.33

5.2

4.4

36.00

36.97

g/l

35.05

5840

50468

(3036489) Thrombin time

864

5509

1.59

35.06

2.0

1.9

20.29

20.32

0.05

739

4682

(3044640) Blood type and Crossmatch panel - Blood

5312

45618

1.24

33.44

2.3

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

557

3207

1.76

33.42

1.5

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7409

65965

1.23

33.01

5.7

5.8

9.41

9.68

umol/l

1.96

7031

62583

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

552

3184

1.75

32.91

1.5

1.3

13.67

22.31

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

5697

49381

1.24

32.69

2.0

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4851

41361

1.24

32.30

2.8

2.5

56.48

73.51

u/l

0.60

4563

38509

(3015736) pH of Urine

6960

61699

1.22

31.91

3.7

3.2

6.25

6.24

0.20

4146

35009

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

755

4779

1.60

31.56

2.1

2.0

95.03

96.68

1.13

727

4569

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

348

1757

1.99

31.55

1.3

734.40

1446.30

pmol/l

0.42

150

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

728

4582

1.61

31.16

2.5

2.3

182.18

171.06

2.69

687

4339

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

506

2892

1.77

31.15

1.7

1.6

7.51

7.57

mmol/l

0.27

491

2782

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

515

2979

1.75

30.41

1.5

1.3

155.83

152.84

au/ml

0.24

131

786

(3000850) Epithelial cells [#/volume] in Urine

3192

26146

1.27

29.59

2.9

2.4

8.58

8.40

e6/l

0.23

2869

23575

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4154

35253

1.24

27.93

2.5

2.2

2.72

2.59

mg/l

3.46

3659

30762

(3019150) Specific gravity of Urine by Refractometry

3997

33801

1.24

27.73

4.3

3.5

1.02

1.20

kg/l

1.34

2705

21769

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10659

99318

1.22

27.30

8.0

7.5

75.63

73.67

u/l

4.22

10176

94801

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

271

1332

2.04

26.55

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1757

13468

1.34

26.52

6.8

5.0

1.06

1.04

mmol/l

2.18

1641

12515

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2936

24154

1.26

25.73

2.8

2.6

828.63

645.98

ng/l

1.54

2404

19905

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

409

2344

1.76

25.00

2.6

30.57

27.48

iu/ml

0.08

152

(3013512) EKG study

4180

35871

1.22

24.57

3.1

2.8

0.50

0.79

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1036

7471

1.41

22.81

9.4

6.9

8.52

7.41

mmol/l

5.80

1007

7207

(3007853) Bacteria identified in Skin by Aerobe culture

1951

15517

1.29

22.25

1.8

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6542

58887

1.18

22.20

7.2

6.0

1.21

1.22

mmol/l

6.33

5650

51251

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3955

34048

1.21

22.01

2.0

147.90

141.88

u/l

0.22

3767

32394

(3026782) Osmolality of Urine

2649

21930

1.24

21.49

3.0

2.6

510.89

509.68

mosm/kgh2o

0.09

2338

19156

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5815

51941

1.18

21.31

6.5

5.4

1.21

1.22

mmol/l

3.20

5455

48442

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

233

1190

1.96

20.60

1.3

1070.00

1056.10

titre

0.05

246

(3002582) Erythrocytes [#/volume] in Urine

4416

38632

1.19

20.32

3.4

2.9

64.96

59.04

e6/l

0.11

3407

28451

(3004775) Volume in Urine collected for unspecified duration

123

490

2.51

20.05

2.8

2.3

624.90

612.81

0.13

389

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9151

85135

1.17

19.61

3.8

3.3

71.76

71.47

ug/l

0.06

8704

81414

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5373

47911

1.18

19.60

3.2

3.1

32.70

28.91

u/l

1.14

5080

45714

(3023368) Bacteria identified in Blood by Culture

3149

26778

1.21

19.50

3.9

3.7

—

(3016750) Collection duration of Urine

104

387

2.69

19.47

2.8

2.2

504.31

506.08

min

0.07

328

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3899

33843

1.20

19.39

2.2

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1351

10478

1.31

18.48

2.9

2.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14615

142555

1.41

18.42

16.9

14.1

67.56

66.38

umol/l

6.22

14501

141185

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14643

142881

1.41

18.35

12.2

10.4

24.81

23.81

u/l

7.24

14377

139858

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2977

25324

1.21

18.20

1.7

1.6

62872114.15

38265486.77

pmol/l

0.81

2556

22041

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1508

11902

1.29

18.06

1.5

61.82

62.56

ug/l

0.18

1249

9860

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

13325

128513

1.24

17.43

12.6

10.8

90.25

90.48

ml/min/173m2

0.64

12283

116827

(3012544) pH of Venous blood

1138

8700

1.33

17.22

4.9

3.6

7.37

7.38

0.62

638

4666

(3023520) Reticulocytes [#/volume] in Blood

981

7363

1.35

16.82

2.7

2.5

73.41

71.86

e9/l

0.62

726

5175

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

448

2913

1.55

16.75

1.6

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10869

103028

1.17

16.70

4.6

4.2

11.03

10.01

mm/h

15.34

10355

98037

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12689

121881

1.21

16.68

6.2

4.9

38.71

37.12

mmol/mol

71.94

12144

116522

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14116

137164

1.29

16.65

14.1

12.2

18.51

19.27

mg/l

2.30

11931

110223

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12524

120161

1.20

16.60

5.5

5.0

14.42

14.36

pmol/l

2.32

11890

113820

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13785

133564

1.26

16.60

6.5

5.9

1.68

1.75

mu/l

9.61

13204

127860

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1125

8648

1.32

16.37

4.9

3.6

5.83

5.81

kpa

0.32

1096

8423

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2039

16903

1.23

15.90

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

972

7352

1.34

15.83

2.4

66.59

67.19

g/l

1.63

905

6845

(3015235) Bicarbonate [Moles/volume] in Capillary blood

459

3055

1.51

15.44

2.8

2.5

24.54

24.68

mmol/l

0.36

450

2995

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2267

19081

1.21

15.17

2.9

2.3

2.48

2.47

g/l

0.34

2090

17687

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2232

18770

1.21

15.06

3.3

3.2

0.84

0.82

mmol/l

5.08

2120

17760

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

324

2007

1.62

14.96

1.5

7.20

7.25

mmol/l

0.11

316

1959

(3009343) pH of Capillary blood

759

5578

1.37

14.91

3.5

2.8

7.41

7.42

1.54

636

4588

(3030467) Casts [#/volume] in Urine by Automated count

3778

33311

1.17

14.87

3.3

2.8

0.29

0.32

e6/l

0.46

2842

23348

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

780

5762

1.37

14.83

3.5

2.9

5.14

5.11

kpa

0.42

759

5517

(3002032) Base excess in Venous blood by calculation

1081

8383

1.30

14.74

5.1

3.6

1.61

1.79

mmol/l

0.93

958

7382

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

176

919

1.92

14.73

1.3

1.2

23.21

9.98

u/ml

0.39

109

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

193

1042

1.85

14.58

1.5

1.4

1.59

1.50

nmol/l

0.55

178

932

(3021589) Normoblasts [#/volume] in Blood

6762

62290

1.14

14.43

11.0

9.6

0.00

e9/l

0.11

5716

50849

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

216

1213

1.78

14.36

1.2

1.1

1.06

1.05

ratio

0.10

175

1013

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1075

8365

1.30

14.28

8.0

8.2

118.38

120.15

g/l

2.29

1041

8166

(3044889) 12 lead EKG panel

9218

86731

1.14

14.27

3.4

3.1

0.37

22.88

0.50

108

(3029396) Erythrocyte agglutination [Presence] in Blood

197

1079

1.83

14.23

3.5

3.2

—

(3045414) Leukocytes [Presence] in Urine

1606

13133

1.24

14.14

2.1

2.0

0.03

0.04

estimate

0.26

359

2926

(4146454) Self-monitoring of blood glucose

158

809

1.95

14.04

3.0

2.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

146

729

2.00

13.94

1.2

68.19

68.22

ug/l

0.00

146

729

(3016502) Oxygen saturation in Arterial blood

1106

8667

1.29

13.92

7.4

7.9

96.35

96.29

0.12

1056

8360

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

355

2291

1.56

13.81

1.2

1.1

74.61

5248.25

iu/ml

0.63

515

(3045424) Erythrocytes [Presence] in Urine

870

6613

1.33

13.70

2.2

2.0

0.02

0.05

estimate

0.79

301

2457

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4750

42818

1.15

13.67

1.4

1.36

1.40

u/ml

0.11

1515

12696

(3022948) Iron [Moles/volume] in Serum or Plasma

2450

20967

1.19

13.59

2.9

2.3

13.77

14.42

umol/l

4.85

2283

19710

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

655

4775

1.38

13.54

3.2

2.7

1.51

1.53

mmol/l

0.05

476

3400

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2019

16978

1.21

13.52

3.0

2.4

22.74

23.52

2.01

1869

15827

(3027801) Oxygen [Partial pressure] in Arterial blood

1253

10013

1.27

13.47

7.5

7.4

13.37

13.60

kpa

0.71

1207

9644

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

795

5980

1.34

13.45

2.1

2.0

4.66

5.86

ug/l

1.45

715

5219

(3027945) Reticulocytes/Erythrocytes in Blood

1279

10256

1.26

13.36

2.6

2.5

1.86

1.76

2.65

1148

9198

(3017181) Myelocytes/Leukocytes in Blood

1395

11303

1.25

13.32

4.5

4.4

0.93

0.91

0.07

363

2782

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1252

10019

1.27

13.30

7.5

7.4

5.01

5.05

kpa

0.80

1209

9655

(3010937) Rubella virus Ab [Presence] in Serum

170

3.11

13.12

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1056

8291

1.29

13.10

7.9

7.2

1.26

1.23

mmol/l

0.44

1043

8143

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1204

9609

1.27

13.08

3.0

2.4

71.82

76.70

ml/min/173m2

3.57

483

3941

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

784

5916

1.34

12.99

1.3

1.2

—

(3025159) Blasts/Leukocytes in Blood

1374

11146

1.25

12.97

4.8

4.7

0.08

0.37

2.49

311

2310

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

771

5810

1.34

12.89

2.5

2.4

127.54

110.45

ng/l

0.67

686

5251

(3002179) Metamyelocytes/Leukocytes in Blood

1333

10790

1.25

12.83

4.3

4.2

0.65

0.71

0.29

348

2662

(3008152) Bicarbonate [Moles/volume] in Arterial blood

701

5213

1.35

12.80

6.1

6.3

24.19

24.39

mmol/l

0.79

666

4972

(3000991) Gas panel - Venous blood

1002

7837

1.29

12.80

9.8

8.5

—

(3021440) Promyelocytes/Leukocytes in Blood

1344

10894

1.25

12.78

4.6

4.5

0.13

0.05

312

2380

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

290

1829

1.59

12.51

1.5

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

916

7105

1.30

12.47

4.0

3.0

4.60

kpa

0.02

893

6907

(3019977) pH of Arterial blood

1247

10055

1.26

12.41

7.5

7.4

7.42

0.01

668

5356

(3026250) Tacrolimus [Mass/volume] in Blood

102

466

2.19

12.36

51.6

42.0

7.21

7.32

ug/l

0.25

424

(3011985) Renin [Units/volume] in Plasma

308

1976

1.56

12.35

1.8

63.48

53.74

mu/l

0.37

274

1799

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

286

1809

1.58

12.20

1.5

1.4

779.66

397.04

pmol/l

0.56

256

1586

(40768446) Kidney Pathology biopsy report

393

2.29

12.17

2.0

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

205

1199

1.71

11.91

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

187

1066

1.76

11.90

1.3

1.2

76.06

81.28

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1111

8907

1.26

11.61

3.6

3.2

1.23

mmol/l

0.25

970

7676

(3010421) pH of Blood

456

3212

1.43

11.57

3.1

2.7

7.41

0.22

446

3178

(3013290) Carbon dioxide [Partial pressure] in Blood

300

1951

1.54

11.36

3.2

2.9

4.91

5.00

kpa

1.37

290

1917

(3012501) Base excess in Blood by calculation

300

1951

1.54

11.36

3.2

2.9

2.20

2.38

mmol/l

0.57

176

1222

(36304419) Bacteria [Presence] in Urine

3628

32437

1.15

11.30

3.2

2.7

0.39

231.57

estimate

0.60

(3004119) Hemoglobin [Mass/volume] in Venous blood

697

5280

1.33

11.27

4.2

3.0

126.87

130.04

g/l

3.55

672

5143

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

548

4002

1.38

11.26

4.1

3.5

48.02

48.51

0.18

537

3944

(3027315) Oxygen [Partial pressure] in Blood

301

1969

1.53

11.11

3.3

3.0

9.13

8.98

kpa

0.67

291

1935

(3027273) Bicarbonate [Moles/volume] in Venous blood

495

3565

1.39

11.07

3.7

3.0

25.20

25.38

mmol/l

0.58

477

3436

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

264

1680

1.57

11.02

2.0

1.6

—

(3012565) Volume of 24 hour Urine

110

542

2.03

11.01

2.1

1.9

1881.64

1988.62

0.54

100

509

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

745

5718

1.31

10.99

2.3

2.2

46.70

19.27

iu/l

0.51

340

2561

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1357

11195

1.23

10.93

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

661

4993

1.33

10.91

8.6

9.0

15.78

16.02

1.32

626

4801

(3003396) Base excess in Arterial blood by calculation

1219

9951

1.24

10.85

7.5

7.3

0.65

0.81

mmol/l

0.74

982

8051

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

383

2653

1.45

10.67

1.1

122.32

119.38

1.12

349

2417

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

451

3218

1.41

10.67

1.3

1.2

263.22

258.02

u/ml

0.16

326

2093

(3023511) Choriogonadotropin [Units/volume] in Urine

961

7657

1.27

10.59

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1427

11889

1.21

10.41

1.6

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

276

2.42

10.39

1.1

—

(3018418) pH of Serum or Plasma

3939

35601

1.14

10.27

4.5

3.8

7.40

1.55

2867

24728

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

793

6197

1.29

10.23

6.9

7.4

24.42

24.73

mmol/l

1.89

784

6160

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1367

11375

1.22

10.10

1.5

1.07

1.20

ratio

6.01

846

6847

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

409

2898

1.42

10.09

1.8

2.0

1.86

1.85

ug/l

0.01

366

2587

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1363

11339

1.22

10.09

1.5

1.14

1.17

ratio

0.67

831

6763

(3037522) Nuclear Ab [Titer] in Serum

2781

24574

1.15

10.07

1.5

1.4

543.84

548.87

titre

0.05

599

5265

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1366

11375

1.21

10.01

1.5

0.96

0.95

ratio

0.18

834

6799

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

117

612

1.91

9.91

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2607

22960

1.16

9.87

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

410

2920

1.41

9.84

3.8

4.8

1.14

1.24

mmol/l

2.70

360

2600

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

516

3818

1.36

9.81

4.2

4.5

1.63

1.67

0.32

487

3603

(3018095) Leukocytes [#/volume] in Urine

5290

48788

1.12

9.76

4.1

3.5

94.75

74.14

e6/l

1.16

3691

31493

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

415

2970

1.40

9.69

1.3

1.2

3.11

3.14

u/ml

0.01

170

1104

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1096

8959

1.23

9.63

2.5

2.2

0.25

0.31

e6/l

0.90

1023

8395

(1616796) Gas panel - Central venous blood

316

2155

1.47

9.60

3.9

2.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

315

2147

1.47

9.60

3.9

2.7

0.84

0.89

nmol/l

0.73

260

1862

(3021960) Folate [Moles/volume] in Serum or Plasma

3649

32961

1.13

9.47

1.7

1.6

20.28

20.77

nmol/l

1.40

3225

28997

(3048929) Epstein Barr virus Ab [Presence] in Serum

791

6242

1.28

9.46

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

680

5274

1.30

9.32

5.8

3.9

23.98

24.36

mmol/l

2.70

673

5209

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3461

31201

1.13

9.23

1.4

1.3

8.41

9.39

u/ml

0.43

1537

13215

(3022493) Free Hemoglobin [Mass/volume] in Plasma

421

2.06

9.22

2.1

3.2

2366.33

2639.60

mg/l

0.04

309

(3042936) Bacteria identified in Isolate by Culture

1917

16577

1.17

9.17

2.1

1.9

—

(4195642) Thrombophilia screening test

373

2655

1.41

9.02

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

591

4520

1.31

9.00

4.2

3.0

1.27

1.33

0.76

591

4489

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2257

19792

1.16

8.99

3.1

3.0

330.37

256.64

ng/l

0.52

1261

11020

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

273

1838

1.49

8.88

1.5

1.4

13.59

16.07

u/ml

—

(4034850) Laboratory test

514

3865

1.33

8.83

9.3

7.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1889

16364

1.17

8.82

1.8

1.7

1223.67

1173.42

nmol/l

1.49

1525

12865

(3042733) HLA Ab [Presence] in Serum

324

2.19

8.77

5.4

4.8

—

(3020491) Glucose [Moles/volume] in Blood

167

1012

1.65

8.63

1.6

5.68

6.01

mmol/l

0.94

135

787

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13039

126874

1.15

8.61

4.6

4.2

5.78

5.61

mmol/l

41.19

12334

120097

(3007930) Methemoglobin/Hemoglobin.total in Blood

465

3460

1.35

8.58

4.3

4.7

0.91

0.90

0.40

438

3263

(3007461) Platelets [#/volume] in Blood

15181

150022

1.53

8.52

22.7

19.0

267.51

269.13

e9/l

2.59

15036

147987

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

424

3117

1.36

8.47

1.9

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1349

11406

1.19

8.40

1.6

1.7

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

281

2.24

8.25

1.0

0.98

1.24

mom

2.50

281

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1055

8734

1.22

8.22

4.7

3.4

88.26

75.11

ng/l

4.03

921

7791

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

394

2878

1.37

8.20

1.3

1.2

4.56

4.11

u/ml

0.28

189

1279

(3000963) Hemoglobin [Mass/volume] in Blood

15187

150125

1.52

8.14

22.8

19.1

132.39

133.06

g/l

11.41

15114

149234

(3034770) Mitochondria Ab [Titer] in Serum

535

4096

1.31

8.12

1.2

1.3

793.18

879.45

titre

0.17

146

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1982

22356

0.87

8.08

1.7

1.8

3.33

3.24

ratio

2.52

1415

16205

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

15183

150086

1.51

8.03

22.9

19.2

39.95

40.42

0.87

15106

149129

(3035941) MCH [Entitic mass]

15182

150077

1.51

8.00

22.5

18.9

29.98

30.06

7.92

15111

149183

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

113

629

1.79

7.97

1.2

1.1

9.25

6.46

u/ml

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

112

622

1.80

7.96

2.0

1.38

1.37

nmol/l

0.03

495

(3026361) Erythrocytes [#/volume] in Blood

15183

150093

1.51

7.95

22.6

19.0

4.44

4.45

e12/l

1.51

15004

147775

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

666

5266

1.27

7.89

2.6

2.0

0.23

g/l

0.34

634

5044

(3010813) Leukocytes [#/volume] in Blood

15184

150111

1.51

7.87

22.7

19.0

6.97

6.64

e9/l

69.71

15006

147766

(3006315) Basophils [#/volume] in Blood

7580

71770

1.10

7.87

6.2

0.04

e9/l

0.82

6738

63168

(3020891) Body temperature

519

3977

1.31

7.85

4.9

4.1

36.93

36.92

°c

0.27

514

3936

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.40

7.83

6.1

12.0

49.46

718.03

e6/l

0.85

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1884

16465

1.16

7.81

1.3

149.15

148.40

u/ml

0.03

799

6529

(3024731) MCV [Entitic mean volume] in Red Blood Cells

15181

150081

1.50

7.80

22.5

18.9

90.12

90.41

15.01

15110

149185

(3001604) Monocytes [#/volume] in Blood

7566

71668

1.10

7.72

6.2

0.53

e9/l

0.92

6747

63158

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

680

5412

1.26

7.64

2.6

1.9

1.19

g/l

0.03

652

5196

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

157

969

1.62

7.61

1.9

1.7

102.76

101.95

0.12

135

870

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

117

2.90

7.60

10.9

10.7

4.44

4.93

mmol/l

0.81

117

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

151

2.64

7.53

7.1

4.6

19.97

35.13

ug/min

1.92

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3714

33972

1.12

7.52

1.4

25.82

28.86

iu/ml

0.53

1112

10225

(3017732) Neutrophils [#/volume] in Blood

2081

18393

1.15

7.35

2.6

3.0

4.51

4.19

e9/l

0.90

1857

16444

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1510

17263

0.86

7.34

1.5

1.6

3.47

3.44

mmol/l

0.34

962

11242

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

911

0.41

7.28

14.6

14.2

638.39

2249.50

nmol/l

0.60

887

(3007566) Smooth muscle Ab [Titer] in Serum

534

4154

1.29

7.24

1.2

1.3

132.34

135.51

titre

0.03

423

(21494890) Protein electrophoresis panel - 24 hour Urine

121

708

1.71

7.22

1.7

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1491

12889

1.17

7.12

3.7

3.6

4.55

pmol/l

0.01

1362

11733

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

336

2451

1.37

7.12

3.2

33.10

33.75

mg/l

0.07

281

2083

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5969

56054

1.10

7.10

1.9

1.8

1.39

1.31

mmol/l

10.26

5087

49006

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

2.49

7.06

5.7

6.3

—

1701.36

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

336

2455

1.37

7.05

3.2

34.84

61.62

mg/l

0.65

284

2085

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

119

699

1.70

7.01

1.1

94.67

96.50

0.30

290

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1712

14977

1.16

6.98

2.1

362.30

379.87

nmol/l

3.56

1585

13985

(3014051) Protein [Presence] in Urine by Test strip

4778

44444

1.10

6.88

3.0

2.7

0.03

0.04

0.12

578

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

300

2165

1.39

6.81

3.4

3.5

0.36

0.37

iu/ml

0.20

168

1147

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

381

2855

1.34

6.80

1.7

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

116

683

1.70

6.79

1.1

97.41

99.86

0.26

287

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.05

6.72

3.7

3.5

—

(3022621) pH of Urine by Test strip

1390

12006

1.17

6.71

2.7

2.3

6.17

0.04

860

7410

(3019225) pH of Specimen

1230

10522

1.18

6.70

4.0

3.5

7.35

0.49

942

7357

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

371

2776

1.34

6.69

1.6

1.5

6.43

6.71

mmol/l

1.77

341

2548

(3013115) Eosinophils [#/volume] in Blood

7798

74249

1.09

6.68

6.3

0.19

0.18

e9/l

6.14

7064

66428

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

977

8194

1.20

6.68

1.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

543

4280

1.27

6.66

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

242

2.18

6.64

1.7

1.4

0.19

0.32

mmol/l

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

607

4860

1.25

6.53

1.5

1.6

8.92

10.09

iu/ml

0.12

121

(3021901) Oxygen saturation in Capillary blood

256

1813

1.41

6.50

3.1

2.6

92.18

91.94

0.25

248

1774

(3005719) IgG [Mass/volume] in Serum or Plasma

1291

11118

1.17

6.48

2.7

2.8

10.57

10.42

g/l

0.81

1192

10329

(3003129) Base excess in Capillary blood by calculation

158

1018

1.55

6.45

2.1

1.9

0.80

0.78

mmol/l

0.02

152

949

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

274

1969

1.39

6.40

1.1

94.61

94.49

0.03

257

1854

(3006504) Eosinophils/Leukocytes in Blood

6906

65482

1.09

6.40

6.3

6.2

2.83

2.76

2.17

6485

61861

(3019198) Lymphocytes [#/volume] in Blood

7724

73602

1.09

6.37

6.3

6.2

1.99

1.97

e9/l

0.68

7049

66326

(3006184) Hemoglobin [Mass/volume] in Capillary blood

330

2447

1.35

6.35

2.6

2.0

130.81

130.51

g/l

0.09

282

1888

(3028026) IgM [Mass/volume] in Serum or Plasma

1011

8556

1.19

6.26

1.8

1.31

1.34

g/l

0.18

936

7983

(4268621) Lupus anticoagulant assay

287

2088

1.38

6.24

2.4

2.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

179

2.34

6.20

3.6

2.4

24.03

26.15

mg/l

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

117

710

1.65

6.16

1.1

1.2

115.33

117.87

0.29

637

(3019069) Monocytes/Leukocytes in Blood

6909

65603

1.09

6.08

6.3

8.06

8.21

5.51

6504

62088

(3000034) Microalbumin [Mass/volume] in Urine

129

805

1.60

6.07

3.1

2.7

151.04

47.03

mg/l

1.50

541

(3022096) Basophils/Leukocytes in Blood

6889

65434

1.09

5.98

6.3

0.68

0.70

2.77

6459

61642

(3014148) Varicella zoster virus Ab [Titer] in Serum

384

2938

1.31

5.97

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.75

5.80

1.6

2.2

—

(4024509) Urine culture

727

6013

1.21

5.80

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

127

801

1.58

5.74

1.1

89.43

92.75

0.67

101

636

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

193

1331

1.45

5.73

1.3

1.2

41.92

25.36

u/l

0.86

172

1167

(3028626) Oxygen [Partial pressure] in Capillary blood

292

2162

1.35

5.72

3.0

2.6

8.81

8.69

kpa

0.49

286

2116

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

383

2950

1.30

5.69

3.5

2.9

24.78

24.77

mmol/l

0.04

359

2750

(3037756) Immunofixation for Serum or Plasma

208

1458

1.43

5.66

1.7

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11977

121652

0.91

5.45

17.9

15.3

331.92

331.66

g/l

2.41

11919

121008

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1215

10565

1.16

5.40

2.3

0.22

g/l

0.83

1143

9989

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

271

2003

1.35

5.40

1.2

1.3

0.53

2.21

nmol/l

0.94

261

1943

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1723

15343

1.13

5.40

2.3

2.4

6.52

6.39

umol/l

0.12

1431

12980

(3016244) Insulin [Units/volume] in Serum or Plasma

201

1414

1.42

5.39

3.6

3.2

26.33

27.02

mu/l

0.11

191

1349

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

275

2038

1.35

5.38

1.2

1.3

0.22

nmol/l

0.02

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

358

2756

1.30

5.37

1.1

—

(21494755) Public health laboratory ask at order entry panel

1751

19404

0.89

5.36

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

171

1169

1.46

5.35

1.5

5.19

5.25

mmol/l

0.47

165

1114

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

119

753

1.58

5.34

1.2

1.3

50.92

70.00

1.02

(4198724) Urine methamphetamine measurement

122

778

1.57

5.30

2.5

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

274

2035

1.35

5.29

1.2

456.96

299.81

titre

0.40

161

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

9.05

5.26

4.3

2.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1115

12713

0.86

5.23

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

148

988

1.50

5.22

1.6

1.8

121.92

127.62

0.50

139

934

(3011648) Oxygen content in Venous blood

149

997

1.49

5.20

3.0

2.2

11.15

10.98

0.21

149

992

(3039000) Anion gap in Blood by calculation

248

1821

1.36

5.17

4.8

6.1

11.36

11.20

mmol/l

0.34

219

1641

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11509

111969

1.09

5.16

3.9

3.8

—

(3018572) Chloride [Moles/volume] in Blood

248

1822

1.36

5.15

4.8

6.1

105.20

105.60

mmol/l

0.57

219

1642

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

530

4300

1.23

5.14

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

3429

31778

1.10

5.08

3.8

3.5

99.32

97.66

4.11

3287

30919

(3011397) Hemoglobin [Presence] in Urine by Test strip

3717

34582

1.09

5.04

4.2

3.5

0.29

0.28

0.01

211

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

141

2.33

4.92

2.1

3.5

0.76

1.14

mmol/l

0.77

103

(3003181) Sodium [Moles/volume] in Urine

213

1543

1.38

4.86

1.5

62.81

64.02

mmol/l

0.16

175

1198

(3004809) Band form neutrophils/Leukocytes in Blood

214

1552

1.38

4.85

2.9

3.0

1.56

1.39

0.27

198

1419

(3044009) aPTT.lupus sensitive (LA screen)

168

2.19

4.80

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

238

1759

1.35

4.79

1.2

29.80

30.77

nmol/l

—

(3002030) Lymphocytes/Leukocytes in Blood

7104

67930

1.08

4.78

6.2

29.34

29.76

3.05

6752

64893

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

298

2278

1.31

4.76

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1102

9612

1.15

4.72

1.6

—

(3022670) pH of Venous cord blood

3.39

4.70

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

244

1820

1.34

4.64

3.4

2.8

32.99

32.61

umol/l

0.08

225

1690

(3023420) DNA double strand Ab [Units/volume] in Serum

884

7595

1.17

4.64

2.6

2.0

8.13

7.23

iu/ml

0.35

239

1802

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

480

3917

1.23

4.46

1.9

—

(3007463) Buprenorphine [Presence] in Urine

2.63

4.43

6.0

8.4

—

(3020650) Glucose [Presence] in Urine

575

1.60

4.43

1.4

1.6

0.07

0.02

estimate

0.43

575

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

282

2165

1.30

4.40

3.3

3.1

1.37

2.92

ratio

3.00

154

1185

(3008898) HLA-B27 [Presence]

925

8021

1.16

4.32

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1059

9274

1.15

4.31

1.5

1.21

1.26

3.06

741

6751

(3024471) HLA-A [Type]

308

1.81

4.30

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

316

2470

1.28

4.30

6.8

5.3

933.44

848.45

iu/ml

0.08

303

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12368

120997

1.09

4.18

17.0

14.7

13.43

13.36

9.04

12231

119586

(3006653) Thiamine [Moles/volume] in Blood

111

735

1.51

4.16

1.5

1.4

130.95

130.87

nmol/l

0.01

111

735

(3000330) Specific gravity of Urine by Test strip

681

5785

1.18

4.14

3.2

2.8

1.02

ratio

2.49

587

5061

(3002079) Sodium [Moles/time] in 24 hour Urine

110

728

1.51

4.14

1.2

1.3

138.45

143.97

mmol/24h

0.43

110

728

(3019174) dRVVT (LA screen)

166

2.10

4.12

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

6972

66855

1.07

4.10

6.1

56.80

56.31

3.37

6684

64293

(3006598) pH of Arterial cord blood

2.97

4.08

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

243

1.89

4.03

1.4

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1070

9425

1.14

4.01

1.6

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

407

3306

1.23

4.00

1.6

397.41

386.58

mu/l

0.13

341

2665

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.49

3.99

1.0

1.2

21.36

21.19

mmol/l

0.08

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

228

1730

1.32

3.92

1.2

1.3

0.16

0.20

nmol/l

0.99

148

1243

(3024932) HLA-DR beta [Type]

297

1.78

3.87

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

498

4150

1.20

3.80

1.3

29.90

16.64

u/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

246

1896

1.30

3.79

3.0

2.4

447.56

9888.05

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

259

3281

0.78

3.76

1.1

0.17

0.23

u/ml

0.19

926

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

420

3458

1.21

3.65

2.3

2.1

7.25

7.28

g/l

0.16

393

3216

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

3451

1.21

3.63

2.3

2.1

3.48

3.61

g/l

1.39

392

3214

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

3452

1.21

3.62

2.3

2.1

4.27

4.31

g/l

0.38

391

3213

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

618

5273

1.17

3.61

1.1

7.87

4.33

eliau/ml

0.52

838

(40768797) Stomach Pathology biopsy report

2051

18849

1.10

3.59

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

239

1851

1.29

3.57

1.1

1.45

1.47

g/l

0.56

225

1698

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

255

1.80

3.51

1.1

1.2

0.57

116.32

mg/l

2.62

184

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5614

53643

1.07

3.51

2.0

1.9

99.06

99.65

pmol/l

0.41

3096

28555

(3017704) Immunofixation for Urine

352

1.67

3.49

1.5

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12773

125350

1.08

3.45

4.0

3.6

1.26

1.19

mmol/l

27.45

12165

119257

(3023430) Cat dander IgE Ab [Units/volume] in Serum

300

3693

0.80

3.43

1.1

4.37

4.65

u/ml

0.09

123

1600

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

372

3047

1.22

3.43

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

3328

1.21

3.43

2.4

2.1

2.78

2.81

g/l

0.23

376

3088

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2601

24212

1.08

3.38

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

125

886

1.41

3.38

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.50

3.37

5.2

3.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

139

1004

1.38

3.36

2.8

3.0

55.74

55.36

0.07

131

871

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

4.98

3.35

6.7

4.5

1.84

2.33

g/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

223

1.83

3.34

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

8261

79953

1.06

3.34

8.5

9.1

4.12

3.93

e9/l

12.28

7387

70245

(3001186) Copper [Moles/volume] in Serum or Plasma

443

1.58

3.30

1.3

1.5

17.66

17.35

umol/l

0.23

375

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

339

2764

1.23

3.29

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

1608

14682

1.10

3.24

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

220

1713

1.28

3.20

1.3

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2128

19694

1.09

3.18

1.8

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

374

4464

0.83

3.18

1.1

3.64

4.89

u/ml

1.07

191

2305

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.78

3.16

1.0

354.00

188.11

pmol/l

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

845

7458

1.14

3.14

1.3

0.52

1.06

u/ml

1.91

559

(3010726) Horse dander IgE Ab [Units/volume] in Serum

360

4303

0.83

3.11

1.1

1.59

1.72

u/ml

0.11

170

2077

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

458

1.55

3.10

1.1

1.3

30.67

20.30

—

(1761482) Bacteria [#/volume] in Urine by Culture

250

1986

1.26

3.10

3.5

—

(3016038) Potassium [Moles/volume] in Urine

579

1.48

3.08

1.3

27.67

32.96

mmol/l

2.16

512

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.65

3.06

1.3

1.0

80.67

97.77

u/ml

—

(3000012) Reticulocyte production index

134

979

1.37

3.06

2.1

2.0

0.97

0.91

0.37

566

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

114

813

1.40

3.02

1.6

1.8

1.65

2.26

u/field

0.99

465

(3014133) Dog dander IgE Ab [Units/volume] in Serum

322

3872

0.82

2.98

1.1

3.11

4.34

u/ml

1.10

157

1851

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

677

7661

0.87

2.96

1.1

0.88

0.86

g/l

0.58

677

7647

(3025468) Yersinia sp identified in Specimen by Organism specific culture

203

1583

1.28

2.95

1.2

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

993

8890

1.12

2.93

1.1

1.44

6.37

u/ml

0.93

113

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

197

1532

1.28

2.93

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

183

1411

1.29

2.91

1.3

64.40

61.00

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

371

1.59

2.90

1.7

1.5

6.60

7.70

mmol/l

1.34

371

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

203

1587

1.28

2.90

1.2

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

379

1.58

2.90

2.5

2.8

0.61

mmol/l

0.14

379

(3004451) EKG impression Narrative

387

1.57

2.89

1.3

1.2

—

(40758558) Short blood count panel - Blood

4293

40878

1.06

2.89

5.3

5.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

359

4255

0.84

2.86

1.1

1.10

1.02

u/ml

0.05

145

1772

(3005988) Vibrio sp identified in Specimen by Organism specific culture

203

1590

1.27

2.86

1.2

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

2673

1.21

2.85

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

213

1679

1.27

2.85

1.2

52.17

47.59

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

360

3001

1.20

2.84

2.1

2.2

0.45

0.50

g/l

0.15

320

2650

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

498

4268

1.17

2.84

1.3

1.08

3.92

u/ml

2.45

299

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3262

30813

1.07

2.82

2.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.56

2.76

6.0

5.7

347.50

398.89

umol/l

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

361

3022

1.19

2.73

2.0

2.1

560.28

436.33

ug/l

0.26

327

2743

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

251

3062

0.81

2.72

3.9

3.8

42.79

31.03

u/ml

0.50

242

2949

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13491

132929

1.08

2.68

4.7

4.2

1.50

1.56

mmol/l

58.32

12895

127172

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

1685

1.26

2.67

1.3

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3789

36028

1.06

2.65

1.5

1.4

2.17

2.12

g/l

1.22

2472

23459

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

357

1.56

2.63

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

2970

1.19

2.63

2.1

9.93

10.01

g/l

0.11

324

2710

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

295

2435

1.21

2.61

1.2

21.27

14.73

u/ml

0.19

120

(3024522) Salmonella sp identified in Specimen by Organism specific culture

211

1681

1.25

2.61

1.3

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

158

1215

1.30

2.60

1.3

58.17

52.33

u/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

320

1.59

2.57

1.9

2.0

23.89

71.61

ug/min

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

232

1873

1.24

2.56

1.2

1.1

1.83

1.08

—

111

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

164

1272

1.29

2.54

2.0

24.12

23.43

mg/l

0.07

464

(37021550) Renin [Units/volume] in Plasma --upright

237

1.68

2.52

1.4

1.3

37.64

78.36

mu/l

2.18

190

(3024928) Oxygen saturation in Venous blood

283

2337

1.21

2.51

5.0

3.2

65.86

62.01

2.33

275

2258

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

159

1231

1.29

2.50

1.1

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

247

2014

1.22

2.49

5.1

3.2

63.96

61.20

1.28

247

2008

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

119

886

1.34

2.48

1.5

1.7

2.17

8.61

nmol/l

0.54

727

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1513

13956

1.09

2.48

4.6

4.1

32.50

32.80

0.53

1166

10188

(3003329) Lymphocytes/Leukocytes in Synovial fluid

125

938

1.33

2.47

1.7

1.6

43.34

39.43

0.44

555

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

671

7500

0.89

2.47

1.1

1.58

1.59

g/l

0.89

671

7492

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13535

133459

1.08

2.43

4.8

4.3

4.74

4.83

mmol/l

31.78

12965

128087

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

142

1090

1.30

2.40

6.4

6.6

12.34

11.59

mg/l

1.08

133

1026

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

279

1.61

2.40

1.7

1.4

5.57

5.43

mmol/l

0.41

279

(3040151) Glucose [Moles/volume] in Capillary blood

147

1134

1.29

2.40

2.3

5.2

7.34

7.06

mmol/l

0.28

116

927

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

117

875

1.33

2.38

1.4

1.5

5.87

5.27

u/l

0.44

101

742

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

450

5150

0.87

2.38

1.1

2.68

2.04

u/ml

0.58

216

2634

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

643

7182

0.89

2.36

1.1

0.62

0.58

ratio

0.61

742

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.10

2.35

6.2

6.1

11.52

10.61

0.71

(3008037) Lactate [Moles/volume] in Venous blood

230

1875

1.22

2.35

3.0

2.5

1.44

1.36

mmol/l

1.07

223

1828

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

323

2720

1.19

2.34

1.4

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

352

1.53

2.34

2.1

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

235

1.65

2.33

1.1

0.58

0.62

umol/24h

0.20

115

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

1.86

2.32

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

147

1140

1.29

2.32

1.1

290.11

303.32

mg/l

1.47

137

1027

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.20

2.29

5.8

4.2

0.19

0.17

mmol/l

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

2.24

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

679

1.37

2.24

1.1

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

270

0.44

2.21

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

2124

1.20

2.21

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

336

2856

1.17

2.21

1.4

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13615

134352

1.08

2.20

5.2

4.7

2.80

2.86

mmol/l

16.94

12994

128478

(3034891) Synovial lining cells/cells in Synovial fluid

530

1.41

2.19

1.5

7.00

4.17

0.53

106

(3047189) Immunofixation for 24 hour Urine

304

1.54

2.14

1.6

2.0

—

(4281824) Cell count and differential, peritoneal fluid

158

1961

0.80

2.10

1.1

—

(4211845) Urine protein measurement

722

1.34

2.08

3.1

2.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

243

1.60

2.08

1.1

1.3

1.18

1.19

mmol/l

0.14

243

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

969

10511

0.91

2.08

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

101

757

1.33

2.07

1.2

19.73

17.05

u/l

0.28

690

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

138

1.80

2.05

1.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

470

4124

1.14

2.03

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

144

1136

1.26

2.02

1.0

1.1

1.02

1.09

u/l

0.83

429

(3006462) Nitrate [Presence] in Urine

649

1.35

2.02

2.8

2.7

—

(3028707) Methadone [Presence] in Urine by Screen method

471

4136

1.14

2.02

3.5

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

672

6029

1.11

2.01

1.8

1.6

0.29

0.28

mg/l

0.17

279

2406

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

101

761

1.32

2.01

1.2

78.14

73.44

u/l

0.34

693

(3029634) Reagin Ab [Titer] in Serum by VDRL

279

2357

1.18

2.00

1.8

1.5

0.60

4.45

titre

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

312

2661

1.17

2.00

2.1

0.00

0.01

g/l

2.29

287

2410

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

693

1.34

2.00

1.6

1.9

132.72

141.26

0.60

645

(3004616) Nuclear Ab [Presence] in Serum

259

2176

1.19

1.99

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1035

9498

1.09

1.96

1.1

350.42

169.35

titre

0.60

252

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

313

2676

1.17

1.95

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

681

1.33

1.91

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

419

1.43

1.91

1.1

95.33

89.22

0.42

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

421

1.42

1.87

1.1

70.20

76.26

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1327

12331

1.08

1.86

6.0

4.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

427

4804

0.88

1.84

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

572

5117

1.12

1.83

10.0

9.4

23.82

24.27

mmol/l

2.97

566

5033

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

151

1.72

1.83

2.4

2.1

7.72

6.63

mmol/l

0.64

(3027456) Digoxin [Moles/volume] in Serum or Plasma

104

802

1.29

1.79

3.9

3.5

0.76

0.81

nmol/l

0.78

636

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

595

1.34

1.78

2.4

157.47

142.64

au/ml

0.13

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.99

1.77

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

708

1.31

1.76

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

207

1.59

1.76

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1063

0.76

1.74

1.6

1.5

0.46

0.50

e9/l

1.43

1063

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

624

1.33

1.73

1.5

1.6

2.56

1.93

u/field

0.19

447

(3003157) Bacteria [#/volume] in Mother's milk

2.02

1.72

5.9

6.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

232

1.55

1.72

1.1

1.0

3.90

8.93

u/ml

0.24

103

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

248

1.53

1.72

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

297

2560

1.16

1.71

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

140

1.71

1.68

20.3

8.5

7.04

6.08

kpa

0.48

140

(3052851) Hemolysis interference index of Serum or Plasma

364

3188

1.14

1.68

2.7

2.6

1.37

2.08

index

1.44

183

1600

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3544

34029

1.05

1.67

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

220

1856

1.18

1.67

2.9

3.6

120.37

629.21

u/ml

2.00

196

1668

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

551

1.34

1.65

1.0

1.1

143.89

301.75

ng/l

0.36

126

(3015377) Calcium [Moles/volume] in Serum or Plasma

4625

44684

1.04

1.65

3.1

3.3

2.35

mmol/l

2.84

4315

41380

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

211

1.56

1.64

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

286

2470

1.16

1.62

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

260

1.49

1.61

1.3

1.2

441.21

401.74

pmol/l

0.16

200

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

409

1.39

1.61

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

409

1.39

1.61

1.5

1.4

—

(21494434) Karyotype in Bone marrow

667

1.30

1.60

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2561

24425

1.05

1.59

2.7

2.5

104.66

101.15

ug/g

0.23

2059

19244

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.32

1.58

1.2

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.32

1.58

1.2

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

396

3505

1.13

1.57

1.3

1.4

554.48

2404.05

e6/l

0.99

332

2724

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

631

5731

1.10

1.56

1.3

46.06

35.46

u/ml

0.33

359

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

579

5237

1.10

1.56

1.6

0.18

5.19

iu/ml

0.68

842

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.19

1.55

5.4

3.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

746

0.73

1.52

1.5

1.7

—

(44806071) Cardiolipin IgM antibody measurement

264

1.47

1.52

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.32

1.51

1.2

1.1

0.60

1.27

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

3.32

1.51

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

429

0.65

1.50

1.6

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

395

3508

1.12

1.50

1.2

3.67

3.58

mmol/l

1.01

370

3324

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

389

3454

1.12

1.48

1.3

28.43

37.06

e6/l

0.22

301

2537

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

641

1.29

1.47

2.0

1.8

29.08

29.90

umol/l

0.32

602

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.89

1.47

1.1

7.53

11.19

u/l

0.44

(40762887) Creatinine [Moles/volume] in Blood

1.94

1.46

1.2

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

451

1.35

1.46

22.0

28.6

112.56

114.02

ug/l

0.05

367

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

962

10263

0.93

1.46

3.5

3.9

14.81

20.09

ug/l

0.35

696

7570

(3035637) Corticotropin [Mass/volume] in Plasma

219

1873

1.17

1.45

1.5

1.7

25.29

33.91

ng/l

1.50

219

1867

(40758292) HTLV I+II Ab panel - Serum

240

0.54

1.44

1.2

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2146

20431

1.05

1.44

2.9

2.5

1.16

1.32

e6/l

0.40

1199

10032

(3022145) Colonoscopy Study observation

1628

15384

1.06

1.43

1.3

1.4

—

(3034614) HLA Ag [Interpretation]

2.30

1.42

1.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.96

1.41

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

155

1291

1.20

1.41

1.7

1.6

47.87

48.61

0.07

792

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

581

5288

1.10

1.41

1.4

8.13

9.66

u/ml

0.19

789

(44806118) Parainfluenza type 4 nucleic acid detection

176

1484

1.18

1.39

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

176

1484

1.18

1.39

1.4

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

582

5300

1.10

1.39

1.3

9.40

6.06

u/ml

0.29

517

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.24

1.39

1.2

1.0

—

(44790048) Parainfluenza type 2 nucleic acid detection

176

1486

1.18

1.38

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

229

1.48

1.38

2.2

2.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

126

1.66

1.37

2.0

2.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

176

1488

1.18

1.36

1.4

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1830

1.16

1.35

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.93

1.35

10.2

7.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

846

1.24

1.34

1.7

1.6

983332.00

1640720.48

iu/ml

0.49

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

468

1.32

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

696

1.26

1.32

1.4

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

1.32

0.0

1.3

—

169.90

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.86

1.32

1.1

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

408

1.34

1.32

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

408

1.34

1.32

1.2

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

530

1.30

2.8

2.5

44.78

48.71

umol/l

0.63

466

(3033099) Centromere Ab [Titer] in Serum

452

1.32

1.30

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

113

1.67

1.29

1.2

1.3

1.83

2.06

mmol/l

0.30

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

753

1.24

1.27

1.1

168.33

160.09

iu/ml

0.14

748

(1617658) Protocol used for examination of sentinel lymph nodes

119

1428

0.83

1.27

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

989

1.21

1.25

1.1

—

0.44

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

146

1226

1.19

1.25

1.1

—

(3034426) Prothrombin time (PT)

508

1.29

1.24

1.3

1.2

27.80

27.71

0.06

508

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6915

67612

1.03

1.22

2.7

2.5

74.46

1364.41

nmol/l

0.50

6508

63638

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

135

1131

1.19

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

224

0.58

1.18

1.2

1.0

0.08

0.12

u/ml

—

148

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

548

1.27

1.17

1.9

2.2

1.05

1.33

ug/l

0.96

524

(3044290) Cell count panel - Cerebral spinal fluid

364

3274

1.11

1.17

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

148

1725

0.85

1.16

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

112

926

1.21

1.15

1.1

0.17

6.66

nmol/l

1.90

154

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

609

0.75

1.15

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.76

1.15

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

282

1.38

1.13

2.2

2.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

820

1.22

1.12

3.0

2.6

—

(40765096) Chromosome analysis panel by Banding

232

1.42

1.12

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

118

1395

0.84

1.11

1.1

1.0

0.15

0.40

u/ml

3.16

295

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

369

1.32

1.10

2.6

3.0

1.82

1.37

0.82

369

(3006922) Hepatitis E virus Ab [Presence] in Serum

141

1196

1.18

1.10

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

458

4965

0.92

1.10

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

1.09

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

283

2524

1.12

1.08

2.0

2.1

0.00

g/l

0.65

250

2224

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

555

1.26

1.08

1.1

1.3

—

(21494815) CD4 cells/Lymphocytes in Specimen

1153

0.83

1.08

2.1

43.39

43.62

0.06

1131

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

435

3968

1.09

1.07

1.3

457.05

465.34

mg/l

0.11

421

3810

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

565

1.25

1.06

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

101

835

1.21

1.06

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

373

4068

0.91

1.04

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

355

3214

1.10

1.04

1.4

1.5

33.41

15.08

iu/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1109

10481

1.06

1.04

1.6

279.93

312.65

mu/l

2.57

967

9361

(3013139) Helicobacter pylori Ag [Presence] in Stool

1140

11935

0.95

1.03

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

263

2344

1.12

1.03

1.3

36.23

55.19

u/ml

0.57

153

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1809

18720

0.96

1.03

1.8

1.6

1.39

1.34

3.15

1606

16887

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

348

1.32

1.02

1.5

1.6

0.40

ug/l

0.01

270

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

141

1207

1.16

1.01

1.5

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

197

1728

1.14

1.01

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

233

2067

1.12

1.00

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

176

1535

1.14

0.98

1.1

—

(4015189) Microbial culture of sputum

180

1.44

0.98

2.0

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

143

1230

1.16

0.97

3.5

3.1

5.29

8.74

nmol/l

0.33

137

1172

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

197

1.42

0.97

1.1

0.06

u/ml

0.09

197

(3002523) Influenza virus A Ag [Presence] in Specimen

375

4069

0.92

0.96

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

128

1094

1.17

0.95

1.5

26.44

23.80

umol/l

0.45

118

1018

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1652

1.13

0.95

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

116

1.55

0.94

1.1

1.47

1.46

umol/24h

0.03

116

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

388

1.28

0.94

2.2

1.8

37149.43

4985.44

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

118

0.51

0.93

2.8

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

504

1.25

0.93

1.9

1.7

53.30

134.65

au/ml

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.88

0.93

1.0

—

(44806420) Estimation of glomerular filtration rate

265

2380

1.11

0.93

2.2

—

(3017509) Phencyclidine [Presence] in Urine

242

1.36

0.92

2.0

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

404

4357

0.92

0.91

1.2

—

(3024316) Viscosity of Plasma

1.81

0.90

1.4

1.5

1.64

1.51

mpas

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

523

4860

1.07

0.87

1.2

4.47

4.30

0.15

844

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.85

0.87

1.3

1.2

25.47

31.33

umol/24h

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1060

0.84

0.86

1.7

1.6

1.16

2.40

u/ml

1.85

255

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.99

0.86

1.0

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

520

1.23

0.85

1.0

1.1

4.00

3.58

iu/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

114

977

1.16

0.85

1.9

1.5

1.02

1.19

promille

0.69

766

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

705

7428

0.94

0.84

1.7

4.26

4.00

mg/l

0.38

541

5384

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

819

0.83

0.84

1.1

1.0

9.43

10.22

u/ml

0.11

546

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.93

0.84

1.0

1.5

—

65000.00

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

947

9893

0.95

0.83

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.77

0.83

1.1

16.60

19.83

g/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

591

5526

1.07

0.83

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.62

0.83

1.1

1.2

1.88

0.18

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

137

0.58

0.83

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

160

1408

1.13

0.82

1.1

1.2

113.25

118.81

pmol/l

0.75

160

1408

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

640

1.20

0.82

1.5

1.4

23.15

20.61

u/ml

0.24

106

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

256

1.32

0.82

1.4

1.3

47.55

46.35

0.06

164

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

677

1.19

0.81

3.2

3.1

8.06

8.83

mg/l

0.46

538

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.87

0.81

1.0

2.4

3.11

2.00

mu/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

159

1401

1.13

0.81

1.3

1.2

55.58

58.65

u/l

0.44

147

1249

(3014765) Yersinia sp identified in Stool by Organism specific culture

409

4382

0.93

0.81

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

815

0.83

0.81

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

108

926

1.16

0.81

1.3

1.5

29666.41

58732.31

e6/l

0.60

610

(3005322) IgE [Units/volume] in Serum or Plasma

1329

12719

1.04

0.80

1.3

153.00

184.76

u/ml

0.86

1242

11887

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

163

1441

1.13

0.79

1.3

0.26

1.52

u/ml

8.87

795

(3005082) Progesterone [Moles/volume] in Serum or Plasma

273

2483

1.10

0.79

1.4

1.5

31.22

34.95

nmol/l

1.30

248

2303

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

1320

1.13

0.78

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

104

892

1.16

0.78

1.2

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

5.3

—

5.81

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

654

6151

1.06

0.78

1.9

2.1

39.74

39.97

u/l

0.10

601

5711

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

400

1.24

0.78

1.2

1.3

139.11

111.43

nmol/l

0.46

308

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.51

0.77

1.2

1.0

11.58

0.65

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

164

1.40

0.77

1.9

1.8

—

(3024263) Appearance of Synovial fluid

481

1.22

0.77

2.0

1.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

599

1.20

0.77

1.2

1.3

—

872.50

—

(42529406) Shigella sp [Presence] in Stool by Culture

411

4391

0.93

0.77

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

146

1286

1.13

0.76

1.3

1.2

0.56

0.66

ratio

3.40

749

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

330

1.27

0.76

1.2

1.9

40.30

41.16

g/l

0.39

330

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

165

1.39

0.75

1.1

1.5

92.03

48.04

ng/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

181

1617

1.12

0.75

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

133

1166

1.14

0.75

1.5

1.4

6.83

6.86

ug/l

0.02

122

1054

(3026389) Candida sp identified in Specimen by Organism specific culture

295

2701

1.09

0.75

1.4

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

620

1.19

0.74

1.5

1.4

13.54

13.69

pmol/l

0.13

527

(3014891) Appearance of Pleural fluid

1.69

0.74

1.3

2.1

—

(3035285) Chloride [Moles/volume] in Venous blood

749

1.17

0.74

2.7

1.9

105.11

105.89

mmol/l

0.94

744

(3028433) Virus identified in Specimen by Culture

376

1.24

0.74

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.63

0.74

5.3

4.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

263

2400

1.09

0.72

3.8

3.2

21.23

23.16

mg/l

0.49

190

1577

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

723

1.17

0.72

1.2

113.11

109.78

0.55

653

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.79

0.72

1.1

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

696

1.17

0.72

2.2

2.0

8.43

9.37

mg/l

0.93

579

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

510

0.80

0.72

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

117

1022

1.14

0.71

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

125

1.43

0.71

1.2

1.1

11.60

14.21

nmol/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

759

0.84

0.71

4.3

4.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.52

0.71

1.1

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.54

0.70

1.5

1.3

1.95

0.59

umol/24h

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.91

0.70

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1203

12432

0.96

0.70

2.8

3.0

35.96

43.46

u/ml

0.77

1172

12048

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

316

3393

0.93

0.69

3.3

3.5

412.21

414.89

u/ml

0.00

268

2910

(3043410) Blood group antigens tested for on Red Blood Cells

344

1.24

0.69

1.3

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

166

1486

1.11

0.68

1.1

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.42

0.68

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

618

6483

0.95

0.68

1.5

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

581

1.18

0.67

1.2

1.3

68.89

54.77

titre

—

(3035320) C reactive protein [Mass/volume] in Body fluid

125

1102

1.13

0.67

2.9

2.5

24.29

24.06

mg/l

0.02

771

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.55

0.67

1.6

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.52

0.66

2.2

1.5

1065.06

532.29

nmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

292

2692

1.08

0.66

2.1

2.0

5.16

5.31

mmol/24h

0.35

260

2477

(40757373) Influenza virus identified in Isolate

170

1.35

0.65

1.7

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

750

1.16

0.65

2.7

1.9

3.96

3.92

mmol/l

0.42

745

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

847

0.86

0.64

2.7

2.6

0.89

0.81

e9/l

0.55

818

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

178

1607

1.10

0.64

1.1

204.88

209.46

mg/l

0.20

160

1424

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

854

1.14

0.63

1.1

9.75

11.72

u/ml

0.15

144

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

172

1551

1.10

0.63

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.72

0.63

2.0

2.1

19.54

30.54

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.72

0.63

1.6

1.5

2.08

2.38

mmol/24h

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

771

1.15

0.63

1.3

1.2

0.31

0.30

g/l

0.46

627

(44813793) Dust mix specific IgE antibody measurement

158

1420

1.11

0.62

1.1

—

(3008295) Osmolality of Serum or Plasma

130

1157

1.12

0.61

1.8

1.6

281.16

280.31

mosm/kgh2o

0.20

107

886

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

105

0.57

0.61

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

258

2376

1.08

0.61

2.0

2.1

0.00

g/l

-0.00

248

2221

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1603

1.10

0.61

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

868

1.14

0.60

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

868

1.14

0.60

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

868

1.14

0.60

1.3

1.6

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

147

1.35

0.60

1.1

1.5

52.83

54.91

—

(3025577) Chromium [Mass/volume] in Blood

306

1.24

0.60

2.2

2.3

2.88

2.94

ug/l

0.03

265

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1606

1.10

0.59

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

409

0.80

0.59

1.6

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

159

1743

0.91

0.59

4.9

5.8

363.56

377.36

umol/l

0.65

138

1527

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

754

0.86

0.59

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

181

1645

1.10

0.59

1.2

35.42

36.38

mg/l

0.12

152

1390

(4133840) Spirometry

307

1.23

0.58

1.3

1.1

—

(3006270) Folate [Moles/volume] in Blood

106

936

1.13

0.58

1.2

1.1

392.09

405.06

nmol/l

0.29

870

(3002331) Protein [Mass/volume] in Peritoneal fluid

174

1.32

0.58

1.4

28.89

26.82

g/l

0.27

133

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

148

1.35

0.58

2.0

2.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.44

0.57

1.5

3.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

136

1220

1.11

0.57

1.3

2.03

1.94

mmol/l

0.34

129

1140

(40768441) Liver Pathology biopsy report

115

1022

1.12

0.57

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

287

2665

1.07

0.56

2.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.45

0.55

1.0

—

5.00

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

171

0.70

0.55

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

373

1.20

0.55

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

734

1.14

0.55

2.8

2.0

1.20

mmol/l

0.44

729

(3023323) Follitropin [Units/volume] in Serum or Plasma

1827

17739

1.03

0.54

1.3

24.28

25.52

iu/l

0.99

1614

15387

(3008757) Leukocyte morphology finding [Identifier] in Blood

107

951

1.12

0.54

2.6

3.0

—

(3032057) Clostridioides difficile [Presence] in Stool

194

1.28

0.54

2.0

1.9

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

212

1.27

0.53

1.6

2.0

528577.09

320792.56

nmol/l

0.23

178

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

392

0.81

0.53

1.1

—

(3042631) Mycobacterium sp identified in Specimen

113

1009

1.12

0.53

2.2

2.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

622

5928

1.05

0.52

1.4

1.3

3.25

3.22

ug/l

0.05

560

5450

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.42

0.51

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

169

1544

1.09

0.51

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

720

1.13

0.51

1.2

1.4

125.02

172.09

nmol/24h

0.28

720

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

683

1.14

0.51

1.9

2.4

214.00

151.79

umol/l

0.50

335

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

414

1.18

0.50

2.9

3.0

28.71

27.76

umol/l

0.20

322

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

190

0.73

0.50

1.1

—

39.17

—

(3045142) Bone marrow Pathology biopsy report

105

939

1.11

0.49

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

141

1281

1.10

0.49

1.8

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

789

1.12

0.49

1.6

8.54

6.58

u/l

0.72

641

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

177

0.73

0.48

1.5

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

111

998

1.11

0.48

2.9

16.17

14.23

index

0.60

593

(3024980) IgG subclass 4 [Mass/volume] in Serum

271

2533

1.07

0.47

1.4

1.5

0.59

0.60

g/l

0.02

214

1984

(3009871) Measles virus Ab [Titer] in Serum

695

0.87

0.47

1.7

1.6

2520.00

3356.82

titre

0.57

107

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

660

1.13

0.47

1.1

50.18

59.25

u/ml

0.55

651

(3000919) Neutrophils/Leukocytes in Pleural fluid

119

1.34

0.47

2.1

1.3

36.38

23.63

0.79

107

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

707

1.13

0.47

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

176

0.73

0.47

1.0

6.82

5.31

u/ml

—

103

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

524

0.85

0.46

1.3

1.4

12.18

11.56

u/l

0.38

507

(4094501) Cardiovascular stress test using bicycle ergometer

317

2983

1.06

0.45

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

966

0.90

0.45

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

286

2685

1.06

0.44

1.1

1.84

2.97

1.56

555

(3028717) Thiamine [Mass/volume] in Blood

228

1.22

0.43

1.3

1.2

61.43

60.78

ug/l

0.10

228

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

554

5298

1.04

0.43

1.5

0.46

0.47

nmol/l

0.04

452

4220

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

320

1.18

0.42

1.0

65.10

76.14

ug/l

1.42

271

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

394

1.16

0.42

1.6

1.8

9.46

8.71

ug/l

0.58

394

(3009214) Lutropin [Units/volume] in Serum or Plasma

648

6219

1.04

0.42

1.3

11.15

12.14

u/l

1.13

551

5115

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.56

0.42

2.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

136

1469

0.92

0.42

1.1

1.0

0.53

2.55

u/ml

2.03

332

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

184

1.24

0.42

2.0

2.1

5.48

8.87

ug/l

0.66

184

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.37

0.41

1.0

1.1

31.48

36.42

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

260

0.80

0.41

1.8

1.5

9.47

38.71

u/l

2.13

226

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

10.60

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

848

1.10

0.40

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

397

3775

1.05

0.40

1.4

300.41

303.19

ug/g

0.08

216

1974

(3025130) Human papilloma virus identified in Specimen

514

5322

0.96

0.40

1.8

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

471

1.14

0.40

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

163

1509

1.08

0.40

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.33

0.40

1.0

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

176

1635

1.07

0.39

1.4

6.76

6.55

g/l

0.37

127

1201

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

286

1.18

0.39

1.7

1.8

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

106

965

1.09

0.39

1.2

9.39

9.43

mm/h

0.01

106

965

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

137

1472

0.93

0.38

2.0

1.8

—

(3023410) Appearance of Cerebral spinal fluid

156

1667

0.93

0.38

1.3

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.38

0.38

1.4

1.0

0.80

1.05

u/field

—

(4062490) Immunoglobulin typing, IgG

173

1611

1.07

0.37

1.4

—

(40768806) Pleura Pathology biopsy report

586

0.88

0.37

1.8

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

175

1631

1.07

0.37

1.4

3.09

2.96

g/l

0.47

126

1199

(3001729) Color of Synovial fluid

1.30

0.37

1.2

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

1.34

0.37

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

335

1.16

0.36

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

175

1632

1.07

0.36

1.4

0.40

0.38

g/l

0.35

128

1201

(3002619) Bacteria identified in Specimen by Culture

363

1.15

0.36

1.1

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

589

1.12

0.36

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

429

1.14

0.36

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

135

1248

1.08

0.36

2.0

19.11

19.69

nmol/l

0.35

129

1201

(3012494) Peanut IgE Ab [Units/volume] in Serum

580

1.12

0.35

1.1

0.22

2.08

u/ml

3.42

340

(3045788) Cell count panel - Pleural fluid

563

0.88

0.35

1.7

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

789

1.10

0.35

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

308

1.16

0.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

364

1.15

0.35

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

364

1.15

0.35

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

364

1.15

0.35

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

364

1.15

0.35

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.42

0.35

1.7

7.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

210

1974

1.06

0.35

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

210

1974

1.06

0.35

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

124

0.72

0.35

1.3

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

305

2898

1.05

0.34

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

734

1.10

0.34

1.6

2.1

51.56

23.69

ug/l

0.45

724

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.34

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

182

1705

1.06

0.34

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

399

3819

1.04

0.33

2.0

2.3

11.29

10.70

mg/l

0.81

375

3607

(3013005) Retinol [Moles/volume] in Serum or Plasma

831

1.09

0.33

2.1

1.7

1.99

1.94

umol/l

0.21

752

(40768795) Lymph node Pathology biopsy report

134

1244

1.07

0.33

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

550

5656

0.97

0.33

1.4

80.62

104.15

pmol/l

2.34

544

5511

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

176

1650

1.06

0.33

1.4

1.3

5.26

5.57

umol/l

0.65

158

1490

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

1325

0.93

0.32

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

109

1.28

0.32

6.3

4.4

7.09

8.17

mmol/l

1.67

109

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

747

1.09

0.32

1.1

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

173

1.21

0.31

2.0

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

218

0.82

0.31

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.34

0.31

1.0

1.1

25.40

13.36

mg/l

—

(21491868) Cryoglobulin [Mass/volume] in Serum

539

1.11

0.31

1.5

1.2

1.31

0.30

g/l

—

(3028300) Cannabinoids [Presence] in Urine

960

9777

0.98

0.31

2.7

1.9

—

(4212803) Bone marrow aspirate examination

1.29

0.30

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

559

1.10

0.30

1.4

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.27

0.29

1.3

23.43

583.83

u/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

140

1309

1.07

0.29

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

560

1.10

0.29

1.4

—

(3027008) Opiates [Presence] in Urine

958

9747

0.98

0.29

2.6

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

221

1.17

0.29

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

110

0.72

0.28

1.0

—

(3027944) Amphetamines [Presence] in Urine

948

9643

0.98

0.28

2.5

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

343

0.87

0.28

1.0

0.04

u/ml

0.03

206

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

194

1836

1.05

0.28

1.9

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1274

12913

0.98

0.28

2.6

2.4

42.00

37.73

u/l

0.47

1054

10952

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

543

1.10

0.28

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1047

10633

0.98

0.28

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

1130

1.07

0.27

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

204

1.17

0.27

1.3

1.1

2.16

1.92

iu/ml

—

107

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

1067

0.93

0.27

2.4

2.5

198.73

228.47

e6/l

1.06

876

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

789

0.92

0.27

1.4

1.2

14.68

21.88

u/l

1.62

668

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.23

0.27

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

421

1.11

0.26

1.9

2.0

9.81

7.78

mmol/l

1.66

421

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

149

1.20

0.26

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

1297

1.06

0.26

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

181

0.82

0.26

2.0

1.6

0.35

1.94

mg/l

—

121

(3000475) Leukocytes [#/volume] in Synovial fluid

275

2632

1.04

0.26

1.8

1.7

11619.85

8204.67

e6/l

0.72

206

1873

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

387

3729

1.03

0.25

1.3

—

(3006245) CD3-CD19+ cells/cells in Blood

682

0.92

0.25

2.3

2.2

9.00

8.14

0.40

641

(3001556) Androgen free Index in Serum or Plasma

253

1.14

0.25

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

160

1.18

0.24

1.3

1.1

0.44

0.64

iu/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

348

1.12

0.24

3.7

4.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1018

9949

1.02

0.24

1.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

179

1.17

0.24

1.0

1.00

0.87

u/ml

0.04

104

(3003434) Protein [Mass/volume] in Pleural fluid

722

1.08

0.23

1.7

1.4

32.19

35.64

g/l

1.33

669

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

358

0.89

0.23

1.7

2.1

8.38

2.36

ug/l

0.40

229

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

710

6916

1.02

0.23

1.6

16.07

11.71

u/ml

0.94

167

1869

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

483

1.09

0.23

1.1

20.08

29.57

iu/ml

0.65

483

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

945

9236

1.02

0.23

1.4

213.03

228.92

miu/ml

0.73

448

4744

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

101

1068

0.94

0.23

5.9

7.1

63.33

37.39

ug/l

0.26

699

(3026692) Albumin [Mass/volume] in Peritoneal fluid

208

1.15

0.22

1.2

1.4

17.01

13.51

g/l

1.28

158

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

436

1.10

0.22

3.5

3.0

67.56

85.62

ng/l

0.54

201

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

686

1.07

0.22

1.6

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.0

—

295.00

—

(3009992) Blasts/cells in Bone marrow

0.00

0.21

0.0

2.2

—

17.00

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.18

0.21

1.2

35.12

32.35

mg/24h

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

158.40

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

524

1.08

0.21

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.16

0.21

75.4

13.9

104.20

104.91

g/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

727

1.07

0.21

1.5

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1908

18777

1.01

0.21

3.0

2.6

5.74

4.96

e6/l

1.18

944

8381

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

0.93

2.24

mg/l

—

115

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

0.55

2.75

mg/l

—

120

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

1.14

2.33

mg/l

—

119

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

1.67

0.69

mg/l

—

117

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

3.79

4.48

mg/l

—

107

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

0.26

1.13

mg/l

—

103

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

1.19

1.72

mg/l

—

122

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

1.03

1.99

mg/l

—

127

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

176

0.85

0.20

2.0

1.5

0.90

2.03

mg/l

—

102

(3000764) Benzodiazepines [Presence] in Urine

960

9714

0.98

0.20

2.7

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

144

0.83

0.20

1.1

136.00

82.44

titre

1.09

144

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1116

10941

1.02

0.20

1.2

1.3

59.02

43.69

au/ml

1.00

622

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

554

1.08

0.20

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

554

1.08

0.20

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

554

1.08

0.20

1.3

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

267

1.12

0.20

1.2

12.13

9.32

pmol/l

0.25

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

277

1.11

0.20

1.0

0.03

0.17

u/ml

1.68

157

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

555

1.08

0.20

1.3

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

466

4530

1.02

0.19

1.3

45.82

44.16

u/ml

0.07

445

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

145

1.17

0.19

1.1

—

(3000494) Fungus identified in Specimen by Culture

1637

16484

0.99

0.19

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.17

0.19

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

269

0.89

0.19

1.0

0.14

0.22

u/ml

—

121

(3011841) English Walnut IgE Ab [Units/volume] in Serum

221

1.13

0.19

1.0

0.02

0.71

u/ml

0.74

162

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1018

0.95

0.18

2.4

557.85

507.76

e6/l

0.52

794

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

605

1.07

0.18

1.2

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

146

1.16

0.18

1.0

0.02

0.10

u/ml

1.49

146

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

803

0.94

0.18

1.4

1.2

72.25

85.56

u/l

1.39

699

(3035611) Eosinophils/Leukocytes in Synovial fluid

1.18

0.18

1.3

1.9

0.33

0.30

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

327

1.10

0.18

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

137

1.16

0.18

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

498

4854

1.02

0.18

1.3

1.4

21.01

25.36

u/l

2.86

415

3972

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

359

3485

1.03

0.17

1.1

15.25

14.91

au/ml

0.03

1030

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

111

1054

1.05

0.17

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

422

0.92

0.17

1.1

0.05

1.37

u/ml

2.49

259

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.12

0.17

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

545

0.93

0.17

1.9

2.0

0.19

0.18

e9/l

0.12

238

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1058

10391

1.01

0.17

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

6132

61297

0.99

0.16

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

172

0.87

0.16

1.1

—

(3002256) Pathology report gross observation

1951

19244

1.01

0.16

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

119

0.84

0.16

1.0

1.3

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.75

0.15

1.0

1.1

0.07

0.06

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

163

1568

1.04

0.15

1.1

7.35

7.93

iu/ml

0.13

471

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

106

1101

0.96

0.15

1.2

254.38

182.00

titre

0.30

185

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

331

1.08

0.14

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

191

0.89

0.14

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

191

0.89

0.14

1.1

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

651

1.06

0.14

3.2

2.7

47.43

44.35

0.68

390

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.79

0.14

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

190

1836

1.03

0.14

3.8

4.9

81.87

117.22

u/ml

0.50

648

(3017446) Testosterone [Moles/volume] in Serum or Plasma

265

2702

0.98

0.14

1.4

1.21

1.57

nmol/l

4.96

226

2326

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1006

9898

1.01

0.14

1.4

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

529

0.94

0.13

1.0

49.23

39.78

ng/l

0.70

391

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

131

1.14

0.13

1.0

1.1

46.90

43.25

mg/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

365

0.93

0.13

1.0

4.93

8.58

u/ml

0.98

365

(3037692) Legionella sp identified in Specimen by Organism specific culture

323

1.08

0.13

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

319

3241

0.98

0.13

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

107

0.84

0.13

1.0

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

527

0.94

0.12

1.0

703.46

785.64

ng/l

0.54

389

(40762365) Oxygen content in Arterial blood by calculation

1.16

0.12

1.8

2.0

15.62

14.76

ml/dl

0.61

(3044941) Cell count panel - Synovial fluid

192

1863

1.03

0.12

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10191

101250

1.01

0.11

3.3

3.0

37.76

34.25

u/l

5.29

9759

97145

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

1062

0.97

0.11

2.2

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

198

0.90

0.11

1.0

—

(4035726) Immunohistochemistry procedure

1073

10581

1.01

0.11

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

127

1226

1.03

0.11

2.1

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

585

0.95

0.11

1.6

1.4

148873.29

43060.19

e6/l

0.50

289

(3011412) CD3 cells [#/volume] in Blood

134

1373

0.97

0.11

2.3

2.4

1348.33

1322.56

e6/l

0.12

110

1171

(3020874) Milk IgE Ab [Units/volume] in Serum

155

1502

1.03

0.11

1.1

1.0

0.93

1.33

u/ml

0.38

438

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

391

0.94

0.10

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

391

0.94

0.10

1.5

1.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.16

0.10

1.0

1.1

0.88

0.05

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.16

0.10

1.6

1.7

240.60

297.49

umol/24h

—

(3010503) CD19 cells [#/volume] in Blood

786

0.96

0.10

2.4

2.7

116.93

312.12

e6/l

1.40

773

(3032868) Hemoglobin electrophoresis panel in Blood

145

0.89

0.10

1.5

—

(3022475) Manganese [Moles/volume] in Blood

115

1.13

0.10

1.2

0.15

0.16

umol/l

0.39

115

(3027231) Wheat IgE Ab [Units/volume] in Serum

461

0.95

0.09

1.1

1.0

0.47

0.92

u/ml

0.87

385

(3005011) Chlamydia sp Ab [Titer] in Serum

241

1.07

0.09

1.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

612

1.04

0.09

1.2

1.3

16.20

18.10

pmol/l

0.68

562

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

450

0.95

0.09

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.14

0.09

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

271

1.07

0.08

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.07

0.08

1.0

8.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

256

0.93

0.08

1.1

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.03

0.08

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

892

8949

0.99

0.08

2.7

1.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

276

0.94

0.08

1.1

1.3

—

(3023419) Bacteria identified in Sputum by Culture

113

1154

0.97

0.08

2.7

2.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

117

1136

1.03

0.08

1.4

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

152

1545

0.98

0.08

1.1

18.69

16.52

u/ml

0.30

691

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

153

0.91

0.08

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

243

1.07

0.07

1.0

0.06

0.35

u/ml

1.07

106

(40758358) Immune stain study

0.83

0.07

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

214

1.07

0.07

1.5

1.8

1.22

1.34

umol/l

1.49

162

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1186

11733

1.01

0.07

2.4

21.02

19.97

au/ml

0.17

136

1603

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.87

0.07

1.6

2.3

65.29

45.73

umol/l

—

(3017569) Oxygen content in Arterial blood

395

0.96

0.06

1.8

2.2

16.28

15.89

0.40

395

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

395

0.96

0.06

1.4

1.9

—

(3025941) Bacteria identified in Stool by Culture

956

9459

1.01

0.06

1.3

1.2

—

(3035880) pH of Pleural fluid

263

0.95

0.06

1.5

1.2

7.42

7.41

0.14

169

(3023487) Leukocytes [#/volume] in Peritoneal fluid

303

0.95

0.06

1.8

2.0

456.55

837.46

e6/l

1.09

185

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

216

1.06

0.06

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

177

1.07

0.06

2.1

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

262

0.95

0.05

1.6

1.9

3134.38

15563.92

e6/l

0.70

110

(3026051) Granulocytes/Leukocytes in Pleural fluid

119

1.09

0.05

1.4

1.5

18.62

21.08

0.19

101

(3044007) Cell count panel - Peritoneal fluid

266

1.05

0.05

1.7

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

523

0.97

0.05

1.0

1033.75

323.53

ng/l

0.56

395

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2376

23583

1.00

0.05

2.3

2.5

2.42

2.43

mmol/l

0.22

2121

21193

(3052592) Norovirus Ag [Presence] in Stool

170

0.94

0.04

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

306

1.04

0.04

2.2

4.1

4.44

4.90

kpa

2.10

306

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

306

1.04

0.04

2.2

4.1

11.25

10.81

kpa

0.26

306

(3020123) Porphyrins [Interpretation] in Serum or Plasma

100

1.09

0.04

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

331

0.96

0.04

1.2

0.42

0.36

nmol/l

0.19

223

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

682

0.98

0.04

1.4

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

218

1.05

0.04

1.0

0.03

0.28

u/ml

0.97

165

(21494814) CD8 cells/Lymphocytes in Specimen

531

0.97

0.04

1.9

2.2

30.27

29.10

0.28

531

(3024891) Influenza virus A+B Ag [Presence] in Specimen

457

4522

1.01

0.03

1.1

—

(40768443) Skin Pathology biopsy report

617

6112

1.00

0.03

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

138

0.94

0.03

2.5

2.1

3.91

3.46

mg/l

0.30

133

(3036670) Protein [Mass/volume] in Synovial fluid

259

1.04

0.03

1.2

1.3

36.98

38.98

g/l

0.27

125

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

101

1017

0.99

0.02

1.5

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

157

0.95

0.02

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

547

0.98

0.02

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

196

0.96

0.01

1.1

1.0

0.74

0.29

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

106

0.94

0.01

1.2

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

754

0.99

0.01

1.0

—

(3049717) Cytology report of Urine Cyto stain

223

2212

1.00

0.00

2.0

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

225

0.97

0.00

2.3

2.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

1131

0.99

0.00

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

164

0.97

0.00

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

117

1.02

0.00

1.2

1.1

1.75

186.14

ug/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

119

1.00

0.00

8.0

6.7

0.52

0.36

umol/l

0.52

106

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

145

1.03

0.00

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

262

0.99

0.00

1.0

0.03

0.23

u/ml

0.50

120

(3007542) Rye IgE Ab [Units/volume] in Serum

146

1.02

0.00

1.1

0.91

15.05

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

146

1.02

0.00

2.1

0.87

0.86

u/field

0.01

146

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

313

0.99

0.00

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

114

1130

1.00

0.00

2.1

76.72

75.29

0.69

106

1090

(3023199) Leukocytes [#/volume] in Pleural fluid

668

1.00

0.00

1.6

1.4

1579.39

3059.94

e6/l

1.25

444

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

375

1.01

0.00

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

375

1.01

0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

375

1.01

0.00

1.0

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

359

1.00

0.00

1.2

1.8

—

382.50

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

0.98

0.00

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

131

1302

1.00

0.00

1.6

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

307

3052

1.00

0.00

1.1

3.94

2.70

eliau/ml

0.52

137

1636

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

501

0.99

0.00

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

108

1.01

0.00

1.6

3.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

157

1.01

0.00

2.5

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

105

1.04

0.00

1.1

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

2.8

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.14

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

227.13

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.94

-0.00

1.0

1.5

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.90

-0.00

1.0

1.1

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.97

-0.00

1.1

1.0

—

3.71

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

40.39

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.88

-0.00

1.2

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.92

-0.00

1.1

37.88

49.41

u/l

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.94

-0.00

1.2

2.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.96

-0.00

1.1

1.4

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.1

—

158.71

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_PREEC_OR_FETGRO and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_PREEC_OR_FETGRO	0.837 [0.72, 0.97]	0.017
Birth year	0.999 [0.99, 1.01]	0.864

During the follow-up period (1.1.1998 — 31.12.2019), 408 out of 58076 females with O15_PREEC_OR_FETGRO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_PREEC_OR_FETGRO.

N-year risk	Females	Males
1	0.074%	No data
5	0.497%	No data
10	1.248%	No data
15	2.567%	No data
20	4.479%	No data

Relationships between endpoints

↥

Index endpoint: O15_PREEC_OR_FETGRO – Pre-eclampsia or poor fetal growth

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-eclampsia or poor fetal growth

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints